[go: up one dir, main page]

TWI849179B - Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element - Google Patents

Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element Download PDF

Info

Publication number
TWI849179B
TWI849179B TW109123631A TW109123631A TWI849179B TW I849179 B TWI849179 B TW I849179B TW 109123631 A TW109123631 A TW 109123631A TW 109123631 A TW109123631 A TW 109123631A TW I849179 B TWI849179 B TW I849179B
Authority
TW
Taiwan
Prior art keywords
liquid crystal
formula
group
crystal alignment
mol
Prior art date
Application number
TW109123631A
Other languages
Chinese (zh)
Other versions
TW202202603A (en
Inventor
王建智
王博世
黃菀婷
Original Assignee
奇美實業股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 奇美實業股份有限公司 filed Critical 奇美實業股份有限公司
Priority to TW109123631A priority Critical patent/TWI849179B/en
Priority to CN202110766729.XA priority patent/CN113930248B/en
Publication of TW202202603A publication Critical patent/TW202202603A/en
Application granted granted Critical
Publication of TWI849179B publication Critical patent/TWI849179B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/52Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K19/54Additives having no specific mesophase characterised by their chemical composition
    • C09K19/56Aligning agents
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J5/00Manufacture of articles or shaped materials containing macromolecular substances
    • C08J5/18Manufacture of films or sheets
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/52Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K19/54Additives having no specific mesophase characterised by their chemical composition
    • C09K19/542Macromolecular compounds
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1337Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
    • G02F1/133711Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by organic films, e.g. polymeric films
    • G02F1/133723Polyimide, polyamide-imide
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08JWORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2379/00Characterised by the use of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen with or without oxygen, or carbon only, not provided for in groups C08J2361/00 - C08J2377/00
    • C08J2379/04Polycondensates having nitrogen-containing heterocyclic rings in the main chain; Polyhydrazides; Polyamide acids or similar polyimide precursors
    • C08J2379/08Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Manufacturing & Machinery (AREA)
  • Nonlinear Science (AREA)
  • Optics & Photonics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Mathematical Physics (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • General Physics & Mathematics (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Liquid Crystal (AREA)

Abstract

The present invention provides a liquid crystal alignment agent, a liquid crystal alignment film and a liquid crystal display element. The liquid crystal alignment agent includes a polymer (A) and a solvent (B). The polymer (A) is manufactured by reacting a specific tetracarboxylic acid dianhydride component (a) with a specific diamine component (b). The liquid crystal alignment film is formed form the liquid crystal alignment agent, and the liquid crystal display element including the liquid crystal alignment film has a lower flicker level after the element is driven.

Description

液晶配向劑、液晶配向膜及液晶顯示元件 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element

本發明是有關於一種液晶配向劑、液晶配向膜及液晶顯示元件,特別是關於一種利用所述液晶配向劑,以製得驅動後即時之閃爍程度較佳的液晶顯示元件。 The present invention relates to a liquid crystal alignment agent, a liquid crystal alignment film and a liquid crystal display element, and in particular to a liquid crystal display element that utilizes the liquid crystal alignment agent to produce a liquid crystal display element with a better degree of flickering immediately after being driven.

用於液晶電視、液晶顯示器等的液晶顯示元件,通常在元件內部設置有控制液晶排列狀態用的液晶配向膜。目前工業上最常見的方法是以棉、尼龍、聚酯等布材沿一方向摩擦形成在電極基板上、由聚醯胺酸及/或將其醯亞胺化之聚醯亞胺所形成的膜表面,進行所謂的摩擦處理而製得此液晶配向膜。 Liquid crystal display elements used in liquid crystal televisions, liquid crystal displays, etc. usually have a liquid crystal alignment film inside the element to control the arrangement of the liquid crystal. The most common method in the industry at present is to rub the surface of the film formed by polyamide and/or imide formed on the electrode substrate with cotton, nylon, polyester and other fabrics in one direction, and perform the so-called friction treatment to produce this liquid crystal alignment film.

在液晶配向膜的配向過程中將膜表面進行摩擦處理為工業上較易於生產的方法。然而,隨著對液晶顯示元件的高效能化、高精細度化、大型化的要求越來越高,在進行摩擦處理的時候,受配向膜表面的損傷、飛塵、因機械力和靜電力所產生的影響與在配向處理面上的不均勻性等種種的問題變得更加顯著。 During the alignment process of the liquid crystal alignment film, the film surface is rubbed, which is a relatively easy-to-produce method in industry. However, with the increasing requirements for high performance, high precision, and large-scale liquid crystal display elements, during the rubbing process, various problems such as damage to the alignment film surface, flying dust, the influence of mechanical force and electrostatic force, and unevenness on the alignment treatment surface have become more prominent.

做為取代摩擦處理的方法,目前已知有利用因偏光的紫外線照射而賦予液晶配向能的光配向法。所稱的光配向法之液晶配向處理是舉凡在反應機制上利用光致異構化(photoisomerization)反應的物質、利用光交聯(photocrosslink)反應的物質、利用光分解反應的物質等。再者,日本特開平9-297313號公報提出,光配向法使用主鏈具有環丁烷等的脂環構造的聚醯亞胺膜。使用聚醯亞胺做為光配向用配向膜的時候,因為此配向膜的耐熱性高於其他類型的配向膜,故看好此種配向膜的應用性。 As a method to replace the friction treatment, it is known that there is a photo-alignment method that uses polarized ultraviolet light to give liquid crystal alignment energy. The so-called photo-alignment method is a liquid crystal alignment treatment that uses a substance that uses a photoisomerization reaction, a substance that uses a photocrosslink reaction, a substance that uses a photodecomposition reaction, etc. in the reaction mechanism. Furthermore, Japanese Patent Publication No. 9-297313 proposes that the photo-alignment method uses a polyimide film with an alicyclic structure such as cyclobutane in the main chain. When using polyimide as an alignment film for photo-alignment, because this alignment film has higher heat resistance than other types of alignment films, the applicability of this alignment film is promising.

光配向法為不摩擦配向處理的方法,其在工業上不僅具有利用簡單製程即可製造的優點,在橫向電場效應技術(In-Plane-Switching;IPS)驅動方式和邊界電場切換廣視角技術(Fringe Field Switching;FFS)驅動方式之液晶顯示元件中,相較於使用摩擦處理法所得的液晶配向膜,使用上述光配向法所得的液晶配向膜時,可望提升液晶顯示元件的對比度和視角特性,因此光配向法為具有前景而備受矚目的液晶配向處理方法。 The optical alignment method is a method of non-rubbing alignment treatment. It has the advantage of being manufactured using a simple process in the industry. In the liquid crystal display elements of the In-Plane-Switching (IPS) driving method and the Fringe Field Switching (FFS) driving method, the liquid crystal alignment film obtained by the optical alignment method is expected to improve the contrast and viewing angle characteristics of the liquid crystal display element compared to the liquid crystal alignment film obtained by the rubbing treatment method. Therefore, the optical alignment method is a promising and highly anticipated liquid crystal alignment treatment method.

然而,透過光配向法所製得的液晶配向膜應用於液晶顯示元件時,所製得之液晶顯示元件仍有驅動後即時之閃爍程度不佳的問題,亦即該液晶配向膜經照光後所製得之液晶顯示元件之積蓄電荷消除緩慢,導致殘留電荷過高,進而生成殘影之問題。由上述可知,為了符合目前光配向IPS型液晶顯示器業者之要求,提供一種可形成驅動後即時之閃爍程度較佳之液晶顯示元件的液晶配向劑,為本技 術領域者努力研究之目標。 However, when the liquid crystal alignment film produced by the photo-alignment method is applied to a liquid crystal display element, the produced liquid crystal display element still has the problem of poor flicker immediately after driving, that is, the accumulated charge of the liquid crystal alignment film after being illuminated is slowly eliminated, resulting in excessive residual charge, and then generating the problem of residual image. From the above, it can be seen that in order to meet the requirements of the current photo-aligned IPS type liquid crystal display industry, providing a liquid crystal alignment agent that can form a liquid crystal display element with better flicker immediately after driving is the goal of the research efforts of the technical field.

本發明之一態樣是在提供一種液晶配向劑,其包含聚合物(A)與溶劑(B)。此液晶配向劑可改善所製得之液晶顯示元件驅動後即時之閃爍程度。此外,本發明之液晶配向劑可選擇性地包含添加劑(C)。 One aspect of the present invention is to provide a liquid crystal alignment agent, which includes a polymer (A) and a solvent (B). This liquid crystal alignment agent can improve the flicker level of the liquid crystal display element produced immediately after being driven. In addition, the liquid crystal alignment agent of the present invention can optionally include an additive (C).

本發明之另一態樣是在提供一種液晶配向膜,其係利用上述的液晶配向劑所形成。 Another aspect of the present invention is to provide a liquid crystal alignment film, which is formed using the above-mentioned liquid crystal alignment agent.

本發明之又一態樣是在提供一種液晶顯示元件,其包含上述之液晶配向膜。 Another aspect of the present invention is to provide a liquid crystal display element, which includes the above-mentioned liquid crystal alignment film.

根據本發明之上述態樣,提出一種液晶配向劑,且此液晶配向劑包含聚合物(A)與溶劑(B),以下析述之。 According to the above aspects of the present invention, a liquid crystal alignment agent is proposed, and the liquid crystal alignment agent comprises a polymer (A) and a solvent (B), which is described below.

聚合物(A) Polymer (A)

本發明之聚合物(A)可由四羧酸二酐組份(a)與二胺組份(b)經聚合反應而製得。 The polymer (A) of the present invention can be prepared by polymerization reaction of tetracarboxylic dianhydride component (a) and diamine component (b).

前述聚合物(A)之較佳具體例可為聚醯胺酸聚合物、聚醯亞胺聚合物、聚醯亞胺系嵌段共聚合物或其組合。其中,聚醯亞胺系嵌段共聚合物之較佳具體例為聚醯胺酸嵌段共聚合物、聚醯亞胺嵌段共聚合物、聚醯胺酸-聚醯亞胺嵌段共聚合物或其任意組合。 Preferred specific examples of the aforementioned polymer (A) may be polyamic acid polymers, polyimide polymers, polyimide-based block copolymers or combinations thereof. Preferred specific examples of polyimide-based block copolymers are polyamic acid block copolymers, polyimide block copolymers, polyamic acid-polyimide block copolymers or any combination thereof.

四羧酸二酐組份(a) Tetracarboxylic dianhydride component (a)

四羧酸二酐化合物(a-1) Tetracarboxylic dianhydride compound (a-1)

本發明之四羧酸二酐組份(a)包含至少一種如下 式(I)所示之四羧酸二酐化合物(a-1):

Figure 109123631-A0305-02-0006-1
The tetracarboxylic dianhydride component (a) of the present invention comprises at least one tetracarboxylic dianhydride compound (a-1) represented by the following formula (I):
Figure 109123631-A0305-02-0006-1

於式(I)中,R1至R4各自獨立地代表氫原子、鹵素原子、碳數為1至6的烷基、碳數為2至6的烯基、碳數為2至6的炔基、含有氟原子且碳數為1至6的一價有機基團或苯基,R1至R4為相同或不相同,且R1、R2、R3及R4之至少一者不為氫原子。 In formula (I), R1 to R4 each independently represents a hydrogen atom, a halogen atom, an alkyl group having 1 to 6 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, an alkynyl group having 2 to 6 carbon atoms, a monovalent organic group having 1 to 6 carbon atoms and containing a fluorine atom, or a phenyl group, R1 to R4 may be the same or different, and at least one of R1 , R2 , R3 and R4 is not a hydrogen atom.

在R1、R2、R3及R4具有立體障礙結構的情況下,所製得之液晶配向劑將使得所形成之液晶顯示元件驅動後即時之閃爍程度不佳。因此,R1、R2、R3及R4較佳為氫原子、甲基或乙基,其中又以甲基為更佳。 When R 1 , R 2 , R 3 and R 4 have a stereo-blocking structure, the liquid crystal alignment agent produced will cause the formed liquid crystal display element to have poor flickering immediately after being driven. Therefore, R 1 , R 2 , R 3 and R 4 are preferably hydrogen atoms, methyl groups or ethyl groups, and methyl groups are more preferred.

如式(I)所示的四羧酸二酐化合物(a-1)的具體例子可例如為如下式(I-1)至式(I-8)所示的化合物。針對驅動後即時之閃爍程度而言,以式(I-1)為較佳。 Specific examples of the tetracarboxylic dianhydride compound (a-1) as shown in formula (I) may be compounds shown in formula (I-1) to formula (I-8) below. In terms of the degree of flash immediately after driving, formula (I-1) is preferred.

Figure 109123631-A0305-02-0006-2
Figure 109123631-A0305-02-0006-2

Figure 109123631-A0305-02-0007-5
Figure 109123631-A0305-02-0007-5

上述之四羧酸二酐化合物(a-1)可單獨一種使用或混合複數種使用。 The above-mentioned tetracarboxylic dianhydride compound (a-1) can be used alone or in combination of two or more.

基於四羧酸二酐組份(a)的總使用量為100莫耳,四羧酸二酐化合物(a-1)的使用量為10莫耳至100莫耳,較佳為20莫耳至80莫耳,且更佳為30莫耳至70莫耳。 Based on the total usage of the tetracarboxylic dianhydride component (a) being 100 mol, the usage of the tetracarboxylic dianhydride compound (a-1) is 10 mol to 100 mol, preferably 20 mol to 80 mol, and more preferably 30 mol to 70 mol.

若四羧酸二酐組份(a)不包含四羧酸二酐化合物(a-1)時,所製得之液晶配向劑將使得所形成之液晶顯示元件驅動後即時之閃爍程度不佳。 If the tetracarboxylic dianhydride component (a) does not contain the tetracarboxylic dianhydride compound (a-1), the resulting liquid crystal alignment agent will cause the formed liquid crystal display element to have poor flickering immediately after being driven.

其他四羧酸二酐化合物(a-2) Other tetracarboxylic dianhydride compounds (a-2)

本發明之四羧酸二酐組份(a)可選擇性地包含其他四羧酸二酐化合物(a-2)。其他四羧酸二酐化合物(a-2)較佳之具體例可為(1)脂肪族四羧酸二酐化合物、(2)脂環族四羧酸二酐化合物、(3)芳香族四羧酸二酐化合物或(4) 如下式(V-1)至式(V-6)所示之四羧酸二酐化合物等。 The tetracarboxylic dianhydride component (a) of the present invention may optionally contain other tetracarboxylic dianhydride compounds (a-2). Preferred specific examples of other tetracarboxylic dianhydride compounds (a-2) may be (1) aliphatic tetracarboxylic dianhydride compounds, (2) alicyclic tetracarboxylic dianhydride compounds, (3) aromatic tetracarboxylic dianhydride compounds or (4) tetracarboxylic dianhydride compounds shown in the following formulas (V-1) to (V-6), etc.

本發明之(1)脂肪族四羧酸二酐化合物包含但不限於乙烷四羧酸二酐或丁烷四羧酸二酐等之脂肪族四羧酸二酐化合物。 The (1) aliphatic tetracarboxylic dianhydride compound of the present invention includes but is not limited to aliphatic tetracarboxylic dianhydride compounds such as ethanetetracarboxylic dianhydride or butanetetracarboxylic dianhydride.

本發明之(2)脂環族四羧酸二酐化合物包含但不限於1,2,3,4-環丁烷四羧酸二酐、1,2-二甲基-1,2,3,4-環丁烷四羧酸二酐、1,3-二甲基-1,2,3,4-環丁烷四羧酸二酐、1,3-二氯-1,2,3,4-環丁烷四羧酸二酐、1,2,3,4-四甲基-1,2,3,4-環丁烷四羧酸二酐、1,2,3,4-環戊烷四羧酸二酐、1,2,4,5-環己烷四羧酸二酐、3,3',4,4'-二環己基四羧酸二酐、順-3,7-二丁基環庚基-1,5-二烯-1,2,5,6-四羧酸二酐、2,3,5-三羧基環戊基醋酸二酐或二環[2.2.2]-辛-7-烯-2,3,5,6-四羧酸二酐等之脂環族四羧酸二酐化合物。 The (2) alicyclic tetracarboxylic acid dianhydride compounds of the present invention include but are not limited to 1,2,3,4-cyclobutanetetracarboxylic acid dianhydride, 1,2-dimethyl-1,2,3,4-cyclobutanetetracarboxylic acid dianhydride, 1,3-dimethyl-1,2,3,4-cyclobutanetetracarboxylic acid dianhydride, 1,3-dichloro-1,2,3,4-cyclobutanetetracarboxylic acid dianhydride, 1,2,3,4-tetramethyl-1,2,3,4-cyclobutanetetracarboxylic acid dianhydride, 1, Alicyclic tetracarboxylic acid dianhydride compounds such as 2,3,4-cyclopentanetetracarboxylic acid dianhydride, 1,2,4,5-cyclohexanetetracarboxylic acid dianhydride, 3,3',4,4'-dicyclohexyltetracarboxylic acid dianhydride, cis-3,7-dibutylcycloheptyl-1,5-diene-1,2,5,6-tetracarboxylic acid dianhydride, 2,3,5-tricarboxycyclopentylacetic acid dianhydride or dicyclo[2.2.2]-oct-7-ene-2,3,5,6-tetracarboxylic acid dianhydride.

本發明之(3)芳香族四羧酸二酐化合物之具體例可包含但不限於3,4-二羧基-1,2,3,4-四氫萘-1-琥珀酸二酐、苯均四羧酸二酐、2,2',3,3'-二苯甲酮四羧酸二酐、3,3',4,4'-二苯甲酮四羧酸二酐、3,3',4,4'-聯苯碸四羧酸二酐、1,4,5,8-萘四羧酸二酐、2,3,6,7-萘四羧酸二酐、3,3'-4,4'-二苯基乙烷四羧酸二酐、3,3',4,4'-二甲基二苯基矽烷四羧酸二酐、3,3',4,4'-四苯基矽烷四羧酸二酐、1,2,3,4-呋喃四羧酸二酐、2,3,3',4'-二苯醚四羧酸二酐、3,3',4,4'-二苯醚四羧酸二酐、4,4'-雙(3,4-二羧基苯氧基)二苯硫醚二酐、2,3,3',4'-二苯硫醚四羧酸二酐、 3,3',4,4'-二苯硫醚四羧酸二酐、4,4'-雙(3,4-二羧基苯氧基)二苯碸二酐、4,4'-雙(3,4-二羧基苯氧基)二苯丙烷二酐、3,3',4,4'-全氟異亞丙基二苯二酸二酐、2,2',3,3'-二苯基四羧酸二酐、2,3,3',4'-二苯基四羧酸二酐、3,3',4,4'-二苯基四羧酸二酐、雙(苯二酸)苯膦氧化物二酐、對-伸苯基-雙(三苯基苯二酸)二酐、間-伸苯基-雙(三苯基苯二酸)二酐、雙(三苯基苯二酸)-4,4'-二苯基醚二酐、雙(三苯基苯二酸)-4,4'-二苯基甲烷二酐、乙二醇-雙(脫水偏苯三酸酯)、丙二醇-雙(脫水偏苯三酸酯)、1,4-丁二醇-雙(脫水偏苯三酸酯)、1,6-己二醇-雙(脫水偏苯三酸酯)、1,8-辛二醇-雙(脫水偏苯三酸酯)、2,2-雙(4-羥苯基)丙烷-雙(脫水偏苯三酸酯)、2,3,4,5-四氫呋喃四羧酸二酐、1,3,3a,4,5,9b-六氫-5-(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-5-甲基-5-(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-5-乙基-5-(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-7-甲基-5-(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-7-乙基-5-(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-8-甲基-5-(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-8-乙基-5-(四氫-2,5-二側氧基 -3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、1,3,3a,4,5,9b-六氫-5,8-二甲基-5-(四氫-2,5-二側氧基-3-呋喃基)-萘并[1,2-c]-呋喃-1,3-二酮、5-(2,5-二側氧基四氫呋喃基)-3-甲基-3-環己烯-1,2-二羧酸二酐等。 Specific examples of the (3) aromatic tetracarboxylic dianhydride compounds of the present invention include, but are not limited to, 3,4-dicarboxy-1,2,3,4-tetrahydronaphthalene-1-succinic dianhydride, pyromellitic dianhydride, 2,2',3,3'-benzophenonetetracarboxylic dianhydride, 3,3',4,4'-benzophenonetetracarboxylic dianhydride, 3,3',4,4'-biphenyl tetracarboxylic dianhydride, 1,4,5,8-naphthalenetetracarboxylic dianhydride, 2,3,6,7-naphthalenetetracarboxylic dianhydride, 3,4-dicarboxy-1,2,3,4-tetrahydronaphthalene-1-succinic dianhydride, 2,2',3,3'-benzophenonetetracarboxylic dianhydride, 3,3',4,4'-benzophenonetetracarboxylic dianhydride, 2,3,6,7-naphthalenetetracarboxylic dianhydride, 2,3,6,7-naphthalenetetracarboxylic dianhydride, 2,2',3,3'-benzophenonetetracarboxylic dianhydride, 2,3,6,7-naphthalene ...2',3,3'-benzophenonetetracarboxylic ,3'-4,4'-diphenylethane tetracarboxylic dianhydride, 3,3',4,4'-dimethyldiphenylsilane tetracarboxylic dianhydride, 3,3',4,4'-tetraphenylsilane tetracarboxylic dianhydride, 1,2,3,4-furan tetracarboxylic dianhydride, 2,3,3',4'-diphenyl ether tetracarboxylic dianhydride, 3,3',4,4'-diphenyl ether tetracarboxylic dianhydride, 4,4'-bis(3,4-dicarboxyphenoxy)diphenyl sulfide dianhydride, 2,3,3',4'-diphenyl Sulfide tetracarboxylic dianhydride, 3,3',4,4'-diphenyl sulfide tetracarboxylic dianhydride, 4,4'-bis(3,4-dicarboxyphenoxy)diphenylsulfone dianhydride, 4,4'-bis(3,4-dicarboxyphenoxy)diphenylpropane dianhydride, 3,3',4,4'-perfluoroisopropylidene diphthalic acid dianhydride, 2,2',3,3'-diphenyltetracarboxylic dianhydride, 2,3,3',4'-diphenyltetracarboxylic dianhydride, 3,3',4,4'-diphenyltetracarboxylic dianhydride anhydride, bis(phthalic acid) phenylphosphine oxide dianhydride, p-phenylene-bis(triphenylphthalic acid) dianhydride, m-phenylene-bis(triphenylphthalic acid) dianhydride, bis(triphenylphthalic acid)-4,4'-diphenyl ether dianhydride, bis(triphenylphthalic acid)-4,4'-diphenylmethane dianhydride, ethylene glycol-bis(dehydrated trimellitate), propylene glycol-bis(dehydrated trimellitate), 1,4-butanediol-bis(dehydrated trimellitate), 1,6-hexanediol-bis( Dehydrated trimellitate), 1,8-octanediol-bis(dehydrated trimellitate), 2,2-bis(4-hydroxyphenyl)propane-bis(dehydrated trimellitate), 2,3,4,5-tetrahydrofurantetracarboxylic dianhydride, 1,3,3a,4,5,9b-hexahydro-5-(tetrahydro-2,5-dioxo-3-furanyl)-naphtho[1,2-c]-furan-1,3-dione, 1,3,3a,4,5,9b-hexahydro-5-methyl-5-( 1,3-dione, 1,3,3a,4,5,9b-hexahydro-5-ethyl-5-(tetrahydro-2,5-dioxo-3-furyl)-naphtho[1,2-c]-furan-1,3-dione, 1,3,3a,4,5,9b-hexahydro-7-methyl-5-(tetrahydro-2,5-dioxo-3-furyl)-naphtho[1,2-c]-furan-1,3-dione -furan-1,3-dione, 1,3,3a,4,5,9b-hexahydro-7-ethyl-5-(tetrahydro-2,5-dioxo-3-furanyl)-naphtho[1,2-c]-furan-1,3-dione, 1,3,3a,4,5,9b-hexahydro-8-methyl-5-(tetrahydro-2,5-dioxo-3-furanyl)-naphtho[1,2-c]-furan-1,3-dione, 1,3,3a,4,5,9b-hexahydro- 8-ethyl-5-(tetrahydro-2,5-dioxo-3-furanyl)-naphtho[1,2-c]-furan-1,3-dione, 1,3,3a,4,5,9b-hexahydro-5,8-dimethyl-5-(tetrahydro-2,5-dioxo-3-furanyl)-naphtho[1,2-c]-furan-1,3-dione, 5-(2,5-dioxo-tetrahydrofuranyl)-3-methyl-3-cyclohexene-1,2-dicarboxylic dianhydride, etc.

根據本發明之(4)如式(V-1)至式(V-6)所示之四羧酸二酐化合物,詳細敘述如下:

Figure 109123631-A0305-02-0010-6
According to (4) of the present invention, the tetracarboxylic dianhydride compounds represented by formula (V-1) to formula (V-6) are described in detail as follows:
Figure 109123631-A0305-02-0010-6

Figure 109123631-A0305-02-0010-7
Figure 109123631-A0305-02-0010-7

Figure 109123631-A0305-02-0011-10
Figure 109123631-A0305-02-0011-10

於式(V-5)中,N1代表含有芳香環的二價基團;r代表1至2的整數;N2及N3可為相同或不同,且可分別代表氫原子或烷基。較佳地,如式(V-5)所示之四羧酸二酐化合物可選自於如下式(V-5-1)至式(V-5-3)所示之化合物。 In formula (V-5), N1 represents a divalent group containing an aromatic ring; r represents an integer from 1 to 2; N2 and N3 may be the same or different and may represent a hydrogen atom or an alkyl group, respectively. Preferably, the tetracarboxylic dianhydride compound represented by formula (V-5) may be selected from the compounds represented by the following formulas (V-5-1) to (V-5-3).

Figure 109123631-A0305-02-0011-277
Figure 109123631-A0305-02-0011-277

Figure 109123631-A0305-02-0012-12
Figure 109123631-A0305-02-0012-12

Figure 109123631-A0305-02-0012-13
Figure 109123631-A0305-02-0012-13

於式(V-6)中,N4代表含有芳香環的二價基團;N5及N6可為相同或不同,且分別地代表氫原子或烷基。較佳地,如式(V-6)所示之四羧酸二酐化合物可選自於如下式(V-6-1)所示之化合物。 In formula (V-6), N4 represents a divalent group containing an aromatic ring; N5 and N6 may be the same or different and represent a hydrogen atom or an alkyl group, respectively. Preferably, the tetracarboxylic dianhydride compound represented by formula (V-6) can be selected from the compounds represented by formula (V-6-1) below.

Figure 109123631-A0305-02-0012-14
Figure 109123631-A0305-02-0012-14

上述之其他四羧酸二酐化合物(a-2)可單獨一種使用或混合複數種使用。 The above-mentioned other tetracarboxylic dianhydride compounds (a-2) can be used alone or in combination of two or more.

基於四羧酸二酐組份(a)的總使用量為100莫耳,其他四羧酸二酐化合物(a-2)的使用量為0莫耳至90莫耳,較佳為20莫耳至80莫耳,且更佳為30莫耳至70莫耳。 Based on the total usage of the tetracarboxylic dianhydride component (a) being 100 mol, the usage of the other tetracarboxylic dianhydride compounds (a-2) is 0 mol to 90 mol, preferably 20 mol to 80 mol, and more preferably 30 mol to 70 mol.

基於二胺組份(b)之使用量為100莫耳,四羧酸二酐組份(a)的使用量範圍為20莫耳至200莫耳,且較佳為30莫耳至120莫耳。 Based on the usage of 100 mol of the diamine component (b), the usage of the tetracarboxylic dianhydride component (a) ranges from 20 mol to 200 mol, and preferably from 30 mol to 120 mol.

二胺組份(b) Diamine component (b)

本發明之二胺組份(b)可包含如下式(II)所示之二胺化合物(b-1)。 The diamine component (b) of the present invention may include a diamine compound (b-1) as shown in the following formula (II).

HN2-X1-M1-A-M2-X2-NH2 (II) HN 2 -X 1 -M 1 -AM 2 -X 2 -NH 2 (II)

於式(II)中,M1與M2分別獨立地代表單鍵、-O-、-S-、-NM3-、酯基、醯胺基、硫酯基、脲基、碳酸酯基或胺基甲酸酯基,其中M3代表氫原子或甲基,且M1與M2可相同或不同;A代表碳數為2至20之伸烷基;X1與X2分別獨立地代表如下式(III-1)至式(III-19)所示之二價有機基團,且X1與X2係選自式(III-1)至式(III-19)中相異之二結構,其中X1與X2之至少一者代表如式(III-17)、式(III-18)或式(III-19)所示之結構。 In formula (II), M1 and M2 each independently represent a single bond, -O-, -S-, -NM3- , an ester group, an amide group, a thioester group, a urea group, a carbonate group or a carbamate group, wherein M3 represents a hydrogen atom or a methyl group, and M1 and M2 may be the same or different; A represents an alkylene group having a carbon number of 2 to 20; X1 and X2 each independently represent a divalent organic group as shown in the following formulas (III-1) to (III-19), and X1 and X2 are selected from two different structures in formulas (III-1) to (III-19), wherein at least one of X1 and X2 represents a structure as shown in formula (III-17), formula (III-18) or formula (III-19).

Figure 109123631-A0305-02-0013-15
Figure 109123631-A0305-02-0013-15

Figure 109123631-A0305-02-0014-17
Figure 109123631-A0305-02-0014-17

於式(III-2)中,X3代表碳數為1至5之伸烷基;於式(III-14)中,X4代表氫原子、鹵素原子、甲基、羥基或甲氧基;於式(III-17)中,X5與X6分別獨立地代表鹵素原子、甲基、羥基或甲氧基;於式(III-18)中,X7與X8分別獨立地代表氫原子、鹵素原子、甲基、羥基或甲氧基,且X7與X8之至少一者不為氫原子。 In formula (III-2), X3 represents an alkylene group having 1 to 5 carbon atoms; in formula (III-14), X4 represents a hydrogen atom, a halogen atom, a methyl group, a hydroxyl group or a methoxy group; in formula (III-17), X5 and X6 each independently represent a halogen atom, a methyl group, a hydroxyl group or a methoxy group; in formula (III-18), X7 and X8 each independently represent a hydrogen atom, a halogen atom, a methyl group, a hydroxyl group or a methoxy group, and at least one of X7 and X8 is not a hydrogen atom.

須說明的是,前述X1與X2選自式(III-1)至式(III-19)中相異之二結構係指X1與X2具有相異之主結構(即式(III-1)至式(III-19)所示之結構),而非僅係官能基之差異。換言之,若X1與X2具有相同之主結構,且兩者之主結構具有相異之官能基時,雖其化學結構具有官能基之差異,但此些二胺化合物亦不屬於本發明之二胺化合物(b-1)。於式(II)中,當X1與X2係選自式(III-1)至式(III-19)中相同之結構式(即相同之主結構,且主結構所鍵結之官能基係相同或相異的)時,所製得之液晶配向劑將使得所形成之液晶顯示元件驅動後即時之閃爍程度不佳。 It should be noted that the two different structures selected from formula (III-1) to formula (III-19) by X1 and X2 refer to X1 and X2 having different main structures (i.e., structures shown in formula (III-1) to formula (III-19)), rather than just the difference in functional groups. In other words, if X1 and X2 have the same main structure and their main structures have different functional groups, although their chemical structures have the difference in functional groups, these diamine compounds do not belong to the diamine compound (b-1) of the present invention. In formula (II), when X1 and X2 are selected from the same structural formula among formula (III-1) to formula (III-19) (i.e., the same main structure, and the functional groups bonded to the main structure are the same or different), the liquid crystal alignment agent prepared will cause the formed liquid crystal display element to have poor flicker immediately after being driven.

於式(II)中,M1與M2分別較佳為單鍵、-O-、-S-、-NM3-、酯基或醯胺基,且更佳為-O-。其次,基於 液晶配向性之觀點,A較佳代表碳數為2至6之伸烷基,且更佳為碳數為2至4之伸烷基。 In formula (II), M1 and M2 are preferably single bonds, -O-, -S-, -NM3- , ester groups or amide groups, and more preferably -O-. Next, from the viewpoint of liquid crystal alignment, A preferably represents an alkylene group having 2 to 6 carbon atoms, and more preferably an alkylene group having 2 to 4 carbon atoms.

於式(III-2)中,X3較佳代表碳數為1至3之伸烷基,且於式(III-14)中,X4較佳代表氫原子或甲基。 In formula (III-2), X 3 preferably represents an alkylene group having 1 to 3 carbon atoms, and in formula (III-14), X 4 preferably represents a hydrogen atom or a methyl group.

於式(II)中,若X1與X2之至少一者不代表如式(III-17)、式(III-18)或式(III-19)所示之結構時,所製得之液晶配向劑將使得所形成之液晶顯示元件驅動後即時之閃爍程度不佳。 In formula (II), if at least one of X1 and X2 does not represent a structure as shown in formula (III-17), formula (III-18) or formula (III-19), the liquid crystal alignment agent prepared will cause the formed liquid crystal display element to have poor flicker immediately after being driven.

在一些實施例中,二胺化合物(b-1)可選自如下式(II-1-1)至式(II-1-3)所示之二胺化合物。 In some embodiments, the diamine compound (b-1) can be selected from the diamine compounds shown in the following formula (II-1-1) to formula (II-1-3).

Figure 109123631-A0305-02-0015-18
Figure 109123631-A0305-02-0015-18

Figure 109123631-A0305-02-0015-19
Figure 109123631-A0305-02-0015-19

Figure 109123631-A0305-02-0015-20
Figure 109123631-A0305-02-0015-20

於式(II-1-1)至式(II-1-3)中,A、M1、M2、X5、X6、X7與X8之定義分別如前所述。 In formula (II-1-1) to formula (II-1-3), A, M 1 , M 2 , X 5 , X 6 , X 7 and X 8 are as defined above.

當二胺化合物(b-1)選自如式(II-1-1)至式(II-1-3)所示之二胺化合物時,所製得之液晶配向劑可更進一步地降低所形成之液晶顯示元件的驅動後即時之閃爍程度。 When the diamine compound (b-1) is selected from the diamine compounds shown in formula (II-1-1) to formula (II-1-3), the prepared liquid crystal alignment agent can further reduce the flicker level of the formed liquid crystal display element immediately after driving.

前述式(II)所示之二胺化合物(b-1)之具體例可包含但不限於如下式(II-2-1)至式(II-2-56)所示之二胺化合物。 Specific examples of the diamine compound (b-1) represented by the aforementioned formula (II) may include but are not limited to the diamine compounds represented by the following formulas (II-2-1) to (II-2-56).

Figure 109123631-A0305-02-0016-22
Figure 109123631-A0305-02-0016-22

Figure 109123631-A0305-02-0016-24
Figure 109123631-A0305-02-0016-24

Figure 109123631-A0305-02-0016-173
Figure 109123631-A0305-02-0016-173

Figure 109123631-A0305-02-0016-174
Figure 109123631-A0305-02-0016-174

Figure 109123631-A0305-02-0016-27
Figure 109123631-A0305-02-0016-27

Figure 109123631-A0305-02-0017-28
Figure 109123631-A0305-02-0017-28

Figure 109123631-A0305-02-0017-175
Figure 109123631-A0305-02-0017-175

Figure 109123631-A0305-02-0017-176
Figure 109123631-A0305-02-0017-176

Figure 109123631-A0305-02-0017-31
Figure 109123631-A0305-02-0017-31

Figure 109123631-A0305-02-0017-32
Figure 109123631-A0305-02-0017-32

Figure 109123631-A0305-02-0018-33
Figure 109123631-A0305-02-0018-33

Figure 109123631-A0305-02-0018-34
Figure 109123631-A0305-02-0018-34

Figure 109123631-A0305-02-0018-35
Figure 109123631-A0305-02-0018-35

Figure 109123631-A0305-02-0018-177
Figure 109123631-A0305-02-0018-177

Figure 109123631-A0305-02-0018-227
Figure 109123631-A0305-02-0018-227

Figure 109123631-A0305-02-0019-39
Figure 109123631-A0305-02-0019-39

Figure 109123631-A0305-02-0019-40
Figure 109123631-A0305-02-0019-40

Figure 109123631-A0305-02-0019-41
Figure 109123631-A0305-02-0019-41

Figure 109123631-A0305-02-0019-42
Figure 109123631-A0305-02-0019-42

Figure 109123631-A0305-02-0019-228
Figure 109123631-A0305-02-0019-228

Figure 109123631-A0305-02-0019-44
Figure 109123631-A0305-02-0019-44

Figure 109123631-A0305-02-0020-45
Figure 109123631-A0305-02-0020-45

Figure 109123631-A0305-02-0020-46
Figure 109123631-A0305-02-0020-46

Figure 109123631-A0305-02-0020-47
Figure 109123631-A0305-02-0020-47

Figure 109123631-A0305-02-0020-231
Figure 109123631-A0305-02-0020-231

Figure 109123631-A0305-02-0020-229
Figure 109123631-A0305-02-0020-229

Figure 109123631-A0305-02-0020-230
Figure 109123631-A0305-02-0020-230

Figure 109123631-A0305-02-0021-51
Figure 109123631-A0305-02-0021-51

於式(II-2-16)與式(II-2-24)中,M3之定義如前所述,在此不另贅述。 In formula (II-2-16) and formula (II-2-24), the definition of M 3 is as described above and will not be further described here.

上述之二胺化合物(b-1)可單獨一種使用或混合複數種使用。 The above-mentioned diamine compound (b-1) can be used alone or in combination of two or more.

基於二胺組份(b)之總使用量為100莫耳,二胺化合物(b-1)的使用量為5莫耳至50莫耳,較佳為5莫耳至40莫耳,且更佳為5莫耳至30莫耳。 Based on the total usage of the diamine component (b) being 100 mol, the usage of the diamine compound (b-1) is 5 mol to 50 mol, preferably 5 mol to 40 mol, and more preferably 5 mol to 30 mol.

若二胺組份(b)不包含二胺化合物(b-1)時,所製得之液晶配向劑將使得所形成之液晶顯示元件驅動後即時之閃爍程度不佳。 If the diamine component (b) does not contain the diamine compound (b-1), the resulting liquid crystal alignment agent will cause the formed liquid crystal display element to have poor flickering immediately after being driven.

二胺化合物(b-2) Diamine compound (b-2)

本發明之二胺組份(b)可包含如下式(IV)所示之二胺化合物(b-2)。 The diamine component (b) of the present invention may include a diamine compound (b-2) represented by the following formula (IV).

Figure 109123631-A0305-02-0021-53
Figure 109123631-A0305-02-0021-53

於式(IV)中,Z1與Z5分別獨立地代表單鍵、-CH2-或-CH2CH2-;Z2與Z4分別獨立地代表-CH2-或-CH2CH2-;Z3代表碳數為1至6之伸烷基或伸環己基;Y1與Y2分別獨立地代表單鍵、-O-、-NH-、-N(CH3)-、 -C(=O)-、-C(=O)O-、-C(=O)NH-、-C(=O)N(CH3)-、-OC(=O)-、-NHC(=O)-或N(CH3)C(=O)-;Y3代表碳數為1至20之直鏈烴基、碳數為3至20之支鏈烴基或碳數為3至20之環狀烴基;且a代表0或1。 In formula (IV), Z1 and Z5 each independently represent a single bond, -CH2- or -CH2CH2- ; Z2 and Z4 each independently represent -CH2- or -CH2CH2- ; Z3 represents an alkylene group or a cyclohexylene group having 1 to 6 carbon atoms; Y1 and Y2 each independently represent a single bond, -O-, -NH-, -N( CH3 )-, -C(=O)-, -C(=O)O- , -C(=O)NH-, -C(=O)N( CH3 )-, -OC(=O)-, -NHC(=O)- or N( CH3 )C(=O)-; Y 3 represents a linear alkyl group having 1 to 20 carbon atoms, a branched alkyl group having 3 to 20 carbon atoms, or a cyclic alkyl group having 3 to 20 carbon atoms; and a represents 0 or 1.

於式(IV)中,Z1與Z5較佳代表單鍵或-CH2-;Z2與Z4較佳代表-CH2-。當Z1與Z5為相同時,Z2與Z4較佳為不相同的。當Z1與Z5為不相同時,Z2與Z4較佳為相同的。 In formula (IV), Z1 and Z5 preferably represent a single bond or -CH2- ; Z2 and Z4 preferably represent -CH2- . When Z1 and Z5 are the same, Z2 and Z4 are preferably different. When Z1 and Z5 are different, Z2 and Z4 are preferably the same.

於式(IV)中,Y1與Y2較佳代表單鍵、-O-、-C(=O)-、-C(=O)O-、-C(=O)NH-、-C(=O)N(CH3)-、-OC(=O)-、-NHC(=O)-或N(CH3)C(=O)-,更佳為分別獨立地代表單鍵或-O-,當Y1與Y2分別獨立地代表單鍵或-O-時,所製得之液晶配向劑可進一步降低所形成之液晶顯示元件驅動後即時之閃爍程度。 In formula (IV), Y1 and Y2 preferably represent a single bond, -O-, -C(=O)-, -C(=O)O-, -C(=O)NH-, -C(=O)N( CH3 )-, -OC(=O)-, -NHC(=O)- or N( CH3 )C(=O)-, and more preferably independently represent a single bond or -O-. When Y1 and Y2 independently represent a single bond or -O-, the resulting liquid crystal alignment agent can further reduce the flicker level of the formed liquid crystal display element immediately after being driven.

基於原料之取得性的觀點,Y3較佳可例如為甲基、乙基、n-丙基、i-丙基、n-丁基、i-丁基、t-丁基、芐基、n-十六烷基或9-芴基甲基。 From the viewpoint of availability of raw materials, Y 3 is preferably, for example, methyl, ethyl, n-propyl, i-propyl, n-butyl, i-butyl, t-butyl, benzyl, n-hexadecyl or 9-fluorenylmethyl.

基於合成容易性之觀點,a較佳為0。 From the perspective of ease of synthesis, a is preferably 0.

式(IV)所示之二胺化合物(b-2)之具體例可包含但不限於如下式(IV-1)至式(IV-46)所示之二胺化合物。 Specific examples of the diamine compound (b-2) represented by formula (IV) may include but are not limited to the diamine compounds represented by the following formulas (IV-1) to (IV-46).

Figure 109123631-A0305-02-0022-278
Figure 109123631-A0305-02-0022-278

Figure 109123631-A0305-02-0023-234
Figure 109123631-A0305-02-0023-234

Figure 109123631-A0305-02-0023-232
Figure 109123631-A0305-02-0023-232

Figure 109123631-A0305-02-0023-280
Figure 109123631-A0305-02-0023-280

Figure 109123631-A0305-02-0023-235
Figure 109123631-A0305-02-0023-235

Figure 109123631-A0305-02-0023-240
Figure 109123631-A0305-02-0023-240

Figure 109123631-A0305-02-0023-239
Figure 109123631-A0305-02-0023-239

Figure 109123631-A0305-02-0023-238
Figure 109123631-A0305-02-0023-238

Figure 109123631-A0305-02-0023-237
Figure 109123631-A0305-02-0023-237

Figure 109123631-A0305-02-0023-242
Figure 109123631-A0305-02-0023-242

Figure 109123631-A0305-02-0024-65
Figure 109123631-A0305-02-0024-65

Figure 109123631-A0305-02-0024-66
Figure 109123631-A0305-02-0024-66

Figure 109123631-A0305-02-0024-67
Figure 109123631-A0305-02-0024-67

Figure 109123631-A0305-02-0024-68
Figure 109123631-A0305-02-0024-68

Figure 109123631-A0305-02-0024-179
Figure 109123631-A0305-02-0024-179

Figure 109123631-A0305-02-0024-72
Figure 109123631-A0305-02-0024-72

Figure 109123631-A0305-02-0024-73
Figure 109123631-A0305-02-0024-73

Figure 109123631-A0305-02-0025-244
Figure 109123631-A0305-02-0025-244

Figure 109123631-A0305-02-0025-243
Figure 109123631-A0305-02-0025-243

Figure 109123631-A0305-02-0025-248
Figure 109123631-A0305-02-0025-248

Figure 109123631-A0305-02-0025-78
Figure 109123631-A0305-02-0025-78

Figure 109123631-A0305-02-0025-249
Figure 109123631-A0305-02-0025-249

Figure 109123631-A0305-02-0025-80
Figure 109123631-A0305-02-0025-80

Figure 109123631-A0305-02-0025-251
Figure 109123631-A0305-02-0025-251

Figure 109123631-A0305-02-0025-250
Figure 109123631-A0305-02-0025-250

Figure 109123631-A0305-02-0026-83
Figure 109123631-A0305-02-0026-83

Figure 109123631-A0305-02-0026-252
Figure 109123631-A0305-02-0026-252

Figure 109123631-A0305-02-0026-85
Figure 109123631-A0305-02-0026-85

Figure 109123631-A0305-02-0026-86
Figure 109123631-A0305-02-0026-86

Figure 109123631-A0305-02-0026-276
Figure 109123631-A0305-02-0026-276

Figure 109123631-A0305-02-0026-253
Figure 109123631-A0305-02-0026-253

Figure 109123631-A0305-02-0026-89
Figure 109123631-A0305-02-0026-89

Figure 109123631-A0305-02-0027-90
Figure 109123631-A0305-02-0027-90

Figure 109123631-A0305-02-0027-91
Figure 109123631-A0305-02-0027-91

Figure 109123631-A0305-02-0027-92
Figure 109123631-A0305-02-0027-92

Figure 109123631-A0305-02-0027-181
Figure 109123631-A0305-02-0027-181

Figure 109123631-A0305-02-0027-254
Figure 109123631-A0305-02-0027-254

Figure 109123631-A0305-02-0027-183
Figure 109123631-A0305-02-0027-183

Figure 109123631-A0305-02-0027-99
Figure 109123631-A0305-02-0027-99

Figure 109123631-A0305-02-0028-100
Figure 109123631-A0305-02-0028-100

Figure 109123631-A0305-02-0028-255
Figure 109123631-A0305-02-0028-255

Figure 109123631-A0305-02-0028-260
Figure 109123631-A0305-02-0028-260

Figure 109123631-A0305-02-0028-259
Figure 109123631-A0305-02-0028-259

Figure 109123631-A0305-02-0028-258
Figure 109123631-A0305-02-0028-258

Figure 109123631-A0305-02-0028-261
Figure 109123631-A0305-02-0028-261

Figure 109123631-A0305-02-0028-256
Figure 109123631-A0305-02-0028-256

於式(IV-1)至式(IV-46)中,Me代表甲基;Et代表乙基;i-Pr代表i-丙基;Bn代表芐基;且Boc代表tert- 丁氧基羰基。 In formula (IV-1) to formula (IV-46), Me represents a methyl group; Et represents an ethyl group; i-Pr represents an i-propyl group; Bn represents a benzyl group; and Boc represents a tert- butoxycarbonyl group.

前述之二胺化合物(b-2)可單獨一種使用或混合複數種使用。 The aforementioned diamine compound (b-2) can be used alone or in combination of two or more.

基於二胺組份(b)之總使用量為100莫耳,二胺化合物(b-2)的使用量為1莫耳至10莫耳,較佳為1莫耳至8莫耳,且更佳為1莫耳至5莫耳。 Based on the total usage of the diamine component (b) being 100 mol, the usage of the diamine compound (b-2) is 1 mol to 10 mol, preferably 1 mol to 8 mol, and more preferably 1 mol to 5 mol.

當二胺組份(b)包含二胺化合物(b-2)時,所製得之液晶配向劑可進一步降低所形成之液晶顯示元件驅動後即時之閃爍程度。 When the diamine component (b) contains the diamine compound (b-2), the resulting liquid crystal alignment agent can further reduce the flicker level of the formed liquid crystal display element immediately after being driven.

其他二胺化合物(b-3) Other diamine compounds (b-3)

本發明之二胺組份可選擇性地包含其他二胺化合物(b-3)。 The diamine component of the present invention may optionally contain other diamine compounds (b-3).

其他二胺化合物(b-3)可包含但不限於1,2-二胺基乙烷、1,3-二胺基丙烷、1,4-二胺基丁烷、1,5-二胺基戊烷、1,6-二胺基己烷、1,7-二胺基庚烷、1,8-二胺基辛烷、1,9-二胺基壬烷、1,10-二胺基癸烷、4,4'-二胺基庚烷、1,3-二胺基-2,2-二甲基丙烷、1,6-二胺基-2,5-二甲基己烷、1,7-二胺基-2,5-二甲基庚烷、1,7-二胺基-4,4-二甲基庚烷、1,7-二胺基-3-甲基庚烷、1,9-二胺基-5-甲基壬烷、2,11-二胺基十二烷、1,12-二胺基十八烷、1,2-雙(3-胺基丙氧基)乙烷、4,4'-二胺基二環己基甲烷、4,4'-二胺基-3,3'-二甲基二環己基胺、1,3-二胺基環己烷、1,4-二胺基環己烷、異佛爾酮二胺、四氫二環戊二烯二胺、三環[6.2.1.0(2,7)]-十一碳烯二甲基二胺、4,4'- 亞甲基雙(環己基胺)、4,4'-二胺基二苯基甲烷、4,4'-二胺基二苯基乙烷、4,4'-二胺基二苯基碸、4,4'-二胺基苯甲醯苯胺、4,4'-二胺基二苯基醚、3,4'-二胺基二苯基醚、1,5-二胺基萘、5-胺基-1-(4'-胺基苯基)-1,3,3-三甲基氫茚、6-胺基-1-(4'-胺基苯基)-1,3,3-三甲基氫茚、六氫-4,7-甲橋伸氫茚基二亞甲基二胺、3,3'-二胺基二苯甲酮、3,4'-二胺基二苯甲酮、4,4'-二胺基二苯甲酮、2,2-雙[4-(4-胺基苯氧基)苯基]丙烷、2,2-雙[4-(4-胺基苯氧基)苯基]六氟丙烷、2,2-雙(4-胺基苯基)六氟丙烷、2,2-雙[4-(4-胺基苯氧基)苯基]碸、1,4-雙(4-胺基苯氧基)環己烷、1,5-雙(4-胺基苯氧基亞甲基)金剛烷、1,4-雙(4-胺基苯氧基)苯、1,3-雙(4-胺基苯氧基)苯、1,3-雙(3-胺基苯氧基)苯、9,9-雙(4-胺基苯基)-10-氫蒽、9,10-雙(4-胺基苯基)蒽[9,10-bis(4-aminophenyl)anthracene]、2,7-二胺基茀、9,9-雙(4-胺基苯基)茀、4,4'-亞甲基-雙(2-氯苯胺)、4,4'-(對-伸苯基異亞丙基)雙苯胺、4,4'-(間-伸苯基異亞丙基)雙苯胺、2,2'-雙[4-(4-胺基-2-三氟甲基苯氧基)苯基]六氟丙烷、4,4'-雙[(4-胺基-2-三氟甲基)苯氧基]-八氟聯苯、5-[4-(4-正戊烷基環己基)環己基]苯基亞甲基-1,3-二胺基苯{5-[4-(4-n-pentylcyclohexyl)cyclohexyl]phenylmethylene-1,3-diaminobenzene}、1,1-雙[4-(4-胺基苯氧基)苯基]-4-(4-乙基苯基)環己烷{1,1-bis[4-(4-aminophenoxy)phenyl]-4-(4- ethylphenyl)cyclohexane}或如下式(VI-1)至式(VI-29)所示之其他二胺化合物。 Other diamine compounds (b-3) may include but are not limited to 1,2-diaminoethane, 1,3-diaminopropane, 1,4-diaminobutane, 1,5-diaminopentane, 1,6-diaminohexane, 1,7-diaminoheptane, 1,8-diaminooctane, 1,9-diaminononane, 1,10-diaminodecane, 4,4'-diaminoheptane, 1,3-diamino-2,2-dimethylpropane, 1,6-diamino-2,5-diamino methylhexane, 1,7-diamino-2,5-dimethylheptane, 1,7-diamino-4,4-dimethylheptane, 1,7-diamino-3-methylheptane, 1,9-diamino-5-methylnonane, 2,11-diaminododecane, 1,12-diaminooctadecane, 1,2-bis(3-aminopropoxy)ethane, 4,4'-diaminodicyclohexylmethane, 4,4'-diamino-3,3'-dimethyldicyclohexylamine, 1,3 -Diaminocyclohexane, 1,4-diaminocyclohexane, isophoronediamine, tetrahydrodicyclopentadienediamine, tricyclo[6.2.1.0(2,7)]-undecenedimethyldiamine, 4,4'- methylenebis(cyclohexylamine), 4,4'-diaminodiphenylmethane, 4,4'-diaminodiphenylethane, 4,4'-diaminodiphenylsulfone, 4,4'-diaminobenzanilide, 4,4'-diaminodiphenylether, 3,4'- Diaminodiphenyl ether, 1,5-diaminonaphthalene, 5-amino-1-(4'-aminophenyl)-1,3,3-trimethylhydroindene, 6-amino-1-(4'-aminophenyl)-1,3,3-trimethylhydroindene, hexahydro-4,7-methylenediamine, 3,3'-diaminobenzophenone, 3,4'-diaminobenzophenone, 4,4'-diaminobenzophenone, 2,2-bis[4-(4-aminophenoxy)phenyl] ] propane, 2,2-bis[4-(4-aminophenoxy)phenyl]hexafluoropropane, 2,2-bis(4-aminophenyl)hexafluoropropane, 2,2-bis[4-(4-aminophenoxy)phenyl]sulfone, 1,4-bis(4-aminophenoxy)cyclohexane, 1,5-bis(4-aminophenoxymethylene)adamantane, 1,4-bis(4-aminophenoxy)benzene, 1,3-bis(4-aminophenoxy)benzene, 1,3-bis(3-aminophenoxy) Benzene, 9,9-bis(4-aminophenyl)-10-hydroanthracene, 9,10-bis(4-aminophenyl)anthracene, 2,7-diaminofluorene, 9,9-bis(4-aminophenyl)fluorene, 4,4'-methylene-bis(2-chloroaniline), 4,4'-(p-phenyleneisopropylidene)bisaniline, 4,4'-(m-phenyleneisopropylidene) Bisaniline, 2,2'-bis[4-(4-amino-2-trifluoromethylphenoxy)phenyl]hexafluoropropane, 4,4'-bis[(4-amino-2-trifluoromethyl)phenoxy]-octafluorobiphenyl, 5-[4-(4-n-pentylcyclohexyl)cyclohexyl]phenylmethylene-1,3-diaminobenzene, 1,1-bis[4-(4-aminophenoxy)phenyl]-4-(4-ethylphenyl)cyclohexane, or other diamine compounds represented by the following formulas (VI-1) to (VI-29).

Figure 109123631-A0305-02-0031-107
Figure 109123631-A0305-02-0031-107

於式(VI-1)中,F1代表-O-、

Figure 109123631-A0305-02-0031-186
Figure 109123631-A0305-02-0031-187
Figure 109123631-A0305-02-0031-188
Figure 109123631-A0305-02-0031-189
Figure 109123631-A0305-02-0031-191
,且F2代表含甾基團、三氟 甲基、氟基、碳數為2至30之烷基或衍生自吡啶、嘧啶、三嗪、哌啶及哌嗪等含氮原子環狀結構的一價基團。 In formula (VI-1), F1 represents -O-,
Figure 109123631-A0305-02-0031-186
,
Figure 109123631-A0305-02-0031-187
,
Figure 109123631-A0305-02-0031-188
,
Figure 109123631-A0305-02-0031-189
or
Figure 109123631-A0305-02-0031-191
, and F 2 represents a steryl group, a trifluoromethyl group, a fluoro group, an alkyl group having 2 to 30 carbon atoms, or a monovalent group derived from a nitrogen atom-containing cyclic structure such as pyridine, pyrimidine, triazine, piperidine and piperazine.

上式(VI-1)所示之其他二胺化合物較佳可為2,4-二胺基苯基甲酸乙酯(2,4-diaminophenyl ethyl formate)、3,5-二胺基苯基甲酸乙酯(3,5-diaminophenyl ethyl formate)、2,4-二胺基苯基甲酸丙酯(2,4-diaminophenyl propyl formate)、3,5-二胺基苯基甲酸丙酯(3,5-diaminophenyl propyl formate)、1-十二烷氧基-2,4-二胺基苯(1-dodecoxy-2,4-diamino-benzene)、1-十六烷氧基-2,4-二胺基苯(1-hexadecoxy-2,4-diaminobenzene)、1-十八烷氧基-2,4-二胺基苯(1-octadecoxy-2,4-diaminobenzene)或下式(VI-1-1)至式(VI-1-6)所示之其他二胺化合物。 The other diamine compounds represented by the above formula (VI-1) are preferably 2,4-diaminophenyl ethyl formate, 3,5-diaminophenyl ethyl formate, 2,4-diaminophenyl propyl formate, 3,5-diaminophenyl propyl formate, 1-dodecoxy-2,4-diamino-benzene, 1-hexadecoxy-2,4-diaminobenzene, 1-octadecoxy-2,4-diaminobenzene or other diamine compounds represented by the following formulas (VI-1-1) to (VI-1-6).

Figure 109123631-A0305-02-0032-108
Figure 109123631-A0305-02-0032-108

Figure 109123631-A0305-02-0032-109
Figure 109123631-A0305-02-0032-109

Figure 109123631-A0305-02-0032-110
Figure 109123631-A0305-02-0032-110

Figure 109123631-A0305-02-0032-111
Figure 109123631-A0305-02-0032-111

Figure 109123631-A0305-02-0032-112
Figure 109123631-A0305-02-0032-112

Figure 109123631-A0305-02-0033-113
Figure 109123631-A0305-02-0033-113

Figure 109123631-A0305-02-0033-192
Figure 109123631-A0305-02-0033-192

於式(VI-2)中,F3代表-O-、

Figure 109123631-A0305-02-0033-194
Figure 109123631-A0305-02-0033-196
Figure 109123631-A0305-02-0033-197
Figure 109123631-A0305-02-0033-198
Figure 109123631-A0305-02-0033-200
,F4及F5代表伸脂肪族環、伸 芳香族環或伸雜環基團,且F6代表碳數為3至18之烷基、碳數為3至18之烷氧基、碳數為1至5之氟烷基、碳數為1至5之氟烷氧基、氰基或鹵素原子。 In formula (VI-2), F 3 represents -O-,
Figure 109123631-A0305-02-0033-194
,
Figure 109123631-A0305-02-0033-196
,
Figure 109123631-A0305-02-0033-197
,
Figure 109123631-A0305-02-0033-198
or
Figure 109123631-A0305-02-0033-200
, F4 and F5 represent an aliphatic ring-extended, aromatic ring-extended or heterocyclic group, and F6 represents an alkyl group having 3 to 18 carbon atoms, an alkoxy group having 3 to 18 carbon atoms, a fluoroalkyl group having 1 to 5 carbon atoms, a fluoroalkoxy group having 1 to 5 carbon atoms, a cyano group or a halogen atom.

上式(VI-2)所示之其他二胺化合物較佳可為如下式(VI-2-1)至式(VI-2-13)所示之二胺化合物:

Figure 109123631-A0305-02-0033-114
The other diamine compounds represented by the above formula (VI-2) are preferably diamine compounds represented by the following formulas (VI-2-1) to (VI-2-13):
Figure 109123631-A0305-02-0033-114

Figure 109123631-A0305-02-0033-115
Figure 109123631-A0305-02-0033-115

Figure 109123631-A0305-02-0033-116
Figure 109123631-A0305-02-0033-116

Figure 109123631-A0305-02-0034-117
Figure 109123631-A0305-02-0034-117

Figure 109123631-A0305-02-0034-263
Figure 109123631-A0305-02-0034-263

Figure 109123631-A0305-02-0034-265
Figure 109123631-A0305-02-0034-265

Figure 109123631-A0305-02-0034-264
Figure 109123631-A0305-02-0034-264

Figure 109123631-A0305-02-0034-121
Figure 109123631-A0305-02-0034-121

Figure 109123631-A0305-02-0034-122
Figure 109123631-A0305-02-0034-122

Figure 109123631-A0305-02-0034-267
Figure 109123631-A0305-02-0034-267

Figure 109123631-A0305-02-0034-266
Figure 109123631-A0305-02-0034-266

Figure 109123631-A0305-02-0034-201
Figure 109123631-A0305-02-0034-201

Figure 109123631-A0305-02-0035-126
Figure 109123631-A0305-02-0035-126

於式(VI-2-10)至式(VI-2-13)中,s可代表3至12的整數。 In formula (VI-2-10) to formula (VI-2-13), s can represent an integer from 3 to 12.

Figure 109123631-A0305-02-0035-127
Figure 109123631-A0305-02-0035-127

於式(VI-3)中,F7代表氫原子、碳數為1至5的醯基、碳數為1至5的烷基、碳數為1至5的烷氧基或鹵素。P1代表1至3的整數。當P1大於1時,複數個F7可為相同或不同。 In formula (VI-3), F7 represents a hydrogen atom, an acyl group having 1 to 5 carbon atoms, an alkyl group having 1 to 5 carbon atoms, an alkoxy group having 1 to 5 carbon atoms, or a halogen. P1 represents an integer from 1 to 3. When P1 is greater than 1, a plurality of F7s may be the same or different.

上述式(VI-3)所示之二胺化合物較佳係選自於(1)P1為1:對-二胺苯、間-二胺苯、鄰-二胺苯或2,5-二胺甲苯等;(2)P1為2:4,4'-二胺基聯苯、2,2'-二甲基-4,4'-二胺基聯苯、3,3'-二甲基-4,4'-二胺基聯苯、3,3'-二甲氧基-4,4'-二胺基聯苯、2,2'-二氯-4,4'-二胺基聯苯、3,3'-二氯-4,4'-二胺基聯苯、2,2',5,5'-四氯-4,4'-二胺基聯苯、2,2'-二氯-4,4'-二胺基-5,5'-二甲氧基聯苯或4,4'-二胺基-2,2'-雙(三氟甲基)聯苯等;(3)P1為3:1,4-雙(4'-胺基苯基)苯等,更佳係選自於對-二胺苯、2,5-二胺甲苯、4,4'-二胺基聯苯、3,3'-二甲氧基-4,4'-二胺基聯苯或1,4-雙(4'-胺基苯基)苯。 The diamine compound represented by the above formula (VI-3) is preferably selected from (1) P1 is 1: p-diaminobenzene, m-diaminobenzene, o-diaminobenzene or 2,5-diaminotoluene; (2) P1 is 2: 4,4'-diaminobiphenyl, 2,2'-dimethyl-4,4'-diaminobiphenyl, 3,3'-dimethyl-4,4'-diaminobiphenyl, 3,3'-dimethoxy-4,4'-diaminobiphenyl, 2,2'-dichloro-4,4'-diaminobiphenyl, 3,3'-dichloro-4,4'-diaminobiphenyl, benzene, 2,2',5,5'-tetrachloro-4,4'-diaminobiphenyl, 2,2'-dichloro-4,4'-diamino-5,5'-dimethoxybiphenyl or 4,4'-diamino-2,2'-bis(trifluoromethyl)biphenyl, etc.; (3) P1 is 3: 1,4-bis(4'-aminophenyl)benzene, etc., preferably selected from p-diaminobenzene, 2,5-diaminotoluene, 4,4'-diaminobiphenyl, 3,3'-dimethoxy-4,4'-diaminobiphenyl or 1,4-bis(4'-aminophenyl)benzene.

Figure 109123631-A0305-02-0036-128
Figure 109123631-A0305-02-0036-128

於上式(VI-4)中,P2代表1至5的整數。式(VI-4)所示之結構較佳係選自於4,4'-二胺基二苯基硫醚。 In the above formula (VI-4), P2 represents an integer from 1 to 5. The structure represented by formula (VI-4) is preferably selected from 4,4'-diaminodiphenyl sulfide.

Figure 109123631-A0305-02-0036-130
Figure 109123631-A0305-02-0036-130

於式(VI-5)中,F8及F10可為相同或不同,且分別代表二價有機基團,F9代表衍生自吡啶、嘧啶、三嗪、哌啶及哌嗪等含氮原子環狀結構的二價基團。 In formula (VI-5), F8 and F10 may be the same or different and each represent a divalent organic group, and F9 represents a divalent group derived from a nitrogen atom-containing cyclic structure such as pyridine, pyrimidine, triazine, piperidine and piperazine.

Figure 109123631-A0305-02-0036-131
Figure 109123631-A0305-02-0036-131

於式(VI-6)中,F11、F12、F13及F14分別可為相同或不同,且可代表碳數為1至12的烴基。P3代表1至3的整數,且P4代表1至20的整數。 In formula (VI-6), F 11 , F 12 , F 13 and F 14 may be the same or different, and may represent a alkyl group having a carbon number of 1 to 12. P3 represents an integer of 1 to 3, and P4 represents an integer of 1 to 20.

Figure 109123631-A0305-02-0036-133
Figure 109123631-A0305-02-0036-133

於式(VI-7)中,F15代表-O-或伸環己烷基,F16代表-CH2-,F17代表伸苯基或伸環己烷基,且F18代表氫原子或碳數1至8的烷基。 In formula (VI-7), F15 represents -O- or a cyclohexylene group, F16 represents -CH2- , F17 represents a phenylene group or a cyclohexylene group, and F18 represents a hydrogen atom or an alkyl group having 1 to 8 carbon atoms.

上式(VI-7)所示之二胺化合物較佳為選自於如下式(VI-7-1)及式(VI-7-2)所示之二胺化合物。 The diamine compound represented by the above formula (VI-7) is preferably selected from the diamine compounds represented by the following formula (VI-7-1) and formula (VI-7-2).

Figure 109123631-A0305-02-0037-134
Figure 109123631-A0305-02-0037-134

Figure 109123631-A0305-02-0037-135
Figure 109123631-A0305-02-0037-135

式(VI-8)至式(VI-29)所示之其他二胺化合物如下所示:

Figure 109123631-A0305-02-0037-137
Other diamine compounds represented by formula (VI-8) to formula (VI-29) are as follows:
Figure 109123631-A0305-02-0037-137

Figure 109123631-A0305-02-0037-138
Figure 109123631-A0305-02-0037-138

Figure 109123631-A0305-02-0037-139
Figure 109123631-A0305-02-0037-139

Figure 109123631-A0305-02-0038-140
Figure 109123631-A0305-02-0038-140

Figure 109123631-A0305-02-0038-142
Figure 109123631-A0305-02-0038-142

Figure 109123631-A0305-02-0038-144
Figure 109123631-A0305-02-0038-144

Figure 109123631-A0305-02-0038-270
Figure 109123631-A0305-02-0038-270

Figure 109123631-A0305-02-0038-146
Figure 109123631-A0305-02-0038-146

Figure 109123631-A0305-02-0038-269
Figure 109123631-A0305-02-0038-269

Figure 109123631-A0305-02-0038-268
Figure 109123631-A0305-02-0038-268

Figure 109123631-A0305-02-0038-150
Figure 109123631-A0305-02-0038-150

Figure 109123631-A0305-02-0039-206
Figure 109123631-A0305-02-0039-206

Figure 109123631-A0305-02-0039-208
Figure 109123631-A0305-02-0039-208

Figure 109123631-A0305-02-0039-272
Figure 109123631-A0305-02-0039-272

Figure 109123631-A0305-02-0039-271
Figure 109123631-A0305-02-0039-271

Figure 109123631-A0305-02-0039-210
Figure 109123631-A0305-02-0039-210

Figure 109123631-A0305-02-0039-212
Figure 109123631-A0305-02-0039-212

Figure 109123631-A0305-02-0039-273
Figure 109123631-A0305-02-0039-273

Figure 109123631-A0305-02-0039-216
Figure 109123631-A0305-02-0039-216

Figure 109123631-A0305-02-0040-160
Figure 109123631-A0305-02-0040-160

Figure 109123631-A0305-02-0040-275
Figure 109123631-A0305-02-0040-275

Figure 109123631-A0305-02-0040-274
Figure 109123631-A0305-02-0040-274

於式(VI-16)至式(VI-19)中,F19較佳係碳數為1至10之烷基或碳數為1至10之烷氧基。於式(VI-20)至式(VI-24)中,F20較佳為氫原子、碳數為1至10之烷基或碳數為1至10之烷氧基。 In formula (VI-16) to formula (VI-19), F19 is preferably an alkyl group having 1 to 10 carbon atoms or an alkoxy group having 1 to 10 carbon atoms. In formula (VI-20) to formula (VI-24), F20 is preferably a hydrogen atom, an alkyl group having 1 to 10 carbon atoms or an alkoxy group having 1 to 10 carbon atoms.

其他二胺化合物(b-3)較佳可包含但不限於1,2-二胺基乙烷、4,4'-二胺基二環己基甲烷、4,4'-二胺基二苯基甲烷、4,4'-二胺基二苯基醚、5-[4-(4-正戊烷基環己基)環己基]苯基亞甲基-1,3-二胺基苯、1,3-雙(3-胺基苯氧基)苯、1,1-雙[4-(4-胺基苯氧基)苯基]-4-(4-乙基苯基)環己烷、2,4-二胺基苯基甲酸乙酯、對-二胺苯、間-二胺苯、鄰-二胺苯、式(VI-1-1)、式(VI-1-2)、式(VI-1-5)、式(VI-2-1)、式(VI-2-11)、式(VI-7-1)、式(VI-25)或式(VI-28)所表示的化合物。 Other diamine compounds (b-3) preferably include but are not limited to 1,2-diaminoethane, 4,4'-diaminodicyclohexylmethane, 4,4'-diaminodiphenylmethane, 4,4'-diaminodiphenyl ether, 5-[4-(4-n-pentylcyclohexyl)cyclohexyl]phenylmethylene-1,3-diaminobenzene, 1,3-bis(3-aminophenoxy)benzene, 1,1-bis[4-(4-aminophenoxy)benzene, [(4-(4-ethylphenyl)cyclohexane]-4-(4-ethylphenyl)cyclohexane, ethyl 2,4-diaminophenylcarboxylate, p-diaminobenzene, m-diaminobenzene, o-diaminobenzene, a compound represented by formula (VI-1-1), formula (VI-1-2), formula (VI-1-5), formula (VI-2-1), formula (VI-2-11), formula (VI-7-1), formula (VI-25) or formula (VI-28).

前述之其他二胺化合物(b-3)可單獨一種使用或混合複數種使用。 The aforementioned other diamine compounds (b-3) can be used alone or in combination of two or more.

基於二胺組份(b)之總使用量為100莫耳,其他二 胺化合物(b-3)之使用量為40莫耳至94莫耳,較佳為52莫耳至94莫耳,且更佳為65莫耳至94莫耳。 Based on the total usage of the diamine component (b) being 100 mol, the usage of the other diamine compound (b-3) is 40 mol to 94 mol, preferably 52 mol to 94 mol, and more preferably 65 mol to 94 mol.

聚合物(A)的製備方法 Preparation method of polymer (A)

本發明之聚醯胺酸聚合物之製備可為一般之方法,較佳地,前述聚醯胺酸聚合物之製備方法包含以下步驟:將包含四羧酸二酐組份(a)與二胺組份(b)之混合物溶於溶劑中,在0℃至100℃之溫度條件下進行聚縮合反應並反應1小時至24小時,接著再將上述之反應溶液以蒸發器進行減壓蒸餾方式,即可得到聚醯胺酸聚合物,或者將上述之反應溶液倒入大量之貧溶劑中,得到一析出物,接著經由減壓乾燥方式將前述析出物進行乾燥處理,即可得到聚醯胺酸聚合物。 The preparation of the polyamine polymer of the present invention can be a general method. Preferably, the preparation method of the polyamine polymer comprises the following steps: dissolving a mixture of a tetracarboxylic dianhydride component (a) and a diamine component (b) in a solvent, carrying out a polycondensation reaction at a temperature of 0°C to 100°C for 1 hour to 24 hours, and then distilling the reaction solution under reduced pressure in an evaporator to obtain a polyamine polymer, or pouring the reaction solution into a large amount of a poor solvent to obtain a precipitate, and then drying the precipitate by reduced pressure drying to obtain a polyamine polymer.

用於聚縮合反應中的溶劑可與下述液晶配向劑中的溶劑(B)相同或不同,且用於聚縮合反應中的溶劑並無特別的限制,只要是可溶解反應物與生成物即可。較佳地,溶劑包含但不限於(1)非質子系極性溶劑,例如:N-甲基-2-吡咯烷酮(N-methyl-2-pyrrolidinone;NMP)、N,N-二甲基乙醯胺、N,N-二甲基甲醯胺、二甲基亞碸、γ-丁內酯、四甲基尿素或六甲基磷酸三胺等之非質子系極性溶劑;(2)酚系溶劑,例如:間-甲酚、二甲苯酚、酚或鹵化酚類等之酚系溶劑。基於混合物之使用量為100重量份,用於聚縮合反應中之溶劑的使用量較佳為200重量份至2000重量份,更佳為300重量份至1800重量份。 The solvent used in the polymerization reaction may be the same as or different from the solvent (B) in the liquid crystal alignment agent described below, and there is no particular limitation on the solvent used in the polymerization reaction, as long as it can dissolve the reactants and the products. Preferably, the solvent includes but is not limited to (1) aprotic polar solvents, such as N-methyl-2-pyrrolidinone (NMP), N,N-dimethylacetamide, N,N-dimethylformamide, dimethyl sulfoxide, γ-butyrolactone, tetramethyl urea or hexamethylphosphoric acid triamide; (2) phenolic solvents, such as m-cresol, xylenol, phenol or halogenated phenols. Based on the usage of 100 parts by weight of the mixture, the usage of the solvent in the polymerization reaction is preferably 200 parts by weight to 2000 parts by weight, and more preferably 300 parts by weight to 1800 parts by weight.

特別地,於聚縮合反應中,溶劑可併用適量的貧溶 劑,其中貧溶劑不會造成聚醯胺酸聚合物析出。貧溶劑可以單獨一種使用或者混合複數種使用,且其包含但不限於(1)醇類,例如:甲醇、乙醇、異丙醇、環己醇、乙二醇、丙二醇、1,4-丁二醇或三乙二醇等之醇類;(2)酮類,例如:丙酮、甲基乙基酮、甲基異丁基酮、環己酮等之酮類;(3)酯類,例如:醋酸甲酯、醋酸乙酯、醋酸丁酯、草酸二乙酯、丙二酸二乙酯或乙二醇乙基醚醋酸酯等之酯類;(4)醚類,例如:二乙基醚、乙二醇甲基醚、乙二醇乙基醚、乙二醇正丙基醚、乙二醇異丙基醚、乙二醇正丁基醚、乙二醇二甲基醚或二乙二醇二甲基醚等之醚類;(5)鹵化烴類,例如:二氯甲烷、1,2-二氯乙烷、1,4-二氯丁烷、三氯乙烷、氯苯或鄰-二氯苯等之鹵化烴類;(6)烴類,例如:四氫呋喃、己烷、庚烷、辛烷、苯、甲苯或二甲苯等之烴類或上述溶劑之任意組合。基於二胺組份(b)的使用量為100重量份,貧溶劑的使用量較佳為0重量份至60重量份,更佳為0重量份至50重量份。 In particular, in the polycondensation reaction, the solvent may be used together with an appropriate amount of a poor solvent, wherein the poor solvent does not cause the polyamine polymer to precipitate. The poor solvent may be used alone or in combination, and includes but is not limited to (1) alcohols, such as methanol, ethanol, isopropanol, cyclohexanol, ethylene glycol, propylene glycol, 1,4-butanediol or triethylene glycol; (2) ketones, such as acetone, methyl ethyl ketone, methyl isobutyl ketone, cyclohexanone; (3) esters, such as methyl acetate, ethyl acetate, butyl acetate, diethyl oxalate, diethyl malonate or ethylene glycol ethyl ether acetate; (4) ethers, For example: ethers such as diethyl ether, ethylene glycol methyl ether, ethylene glycol ethyl ether, ethylene glycol n-propyl ether, ethylene glycol isopropyl ether, ethylene glycol n-butyl ether, ethylene glycol dimethyl ether or diethylene glycol dimethyl ether; (5) halogenated hydrocarbons such as dichloromethane, 1,2-dichloroethane, 1,4-dichlorobutane, trichloroethane, chlorobenzene or o-dichlorobenzene; (6) hydrocarbons such as tetrahydrofuran, hexane, heptane, octane, benzene, toluene or xylene or any combination of the above solvents. Based on the usage of the diamine component (b) being 100 parts by weight, the usage of the poor solvent is preferably 0 to 60 parts by weight, and more preferably 0 to 50 parts by weight.

本發明之聚醯亞胺聚合物之製備可為一般之方法,較佳地,聚醯亞胺聚合物之製備方法先將混合物溶解於溶液中,其中混合物包含四羧酸二酐組份(a)與二胺組份(b),並進行聚合反應,以形成聚醯胺酸聚合物。接著,在脫水劑及觸媒的存在下,進一步加熱,並進行脫水閉環反應,使得聚醯胺酸聚合物中的醯胺酸官能基經由脫水閉環反應轉變成醯亞胺官能基(即醯亞胺化),而得到聚醯亞胺聚合物。 The preparation of the polyimide polymer of the present invention can be a general method. Preferably, the preparation method of the polyimide polymer first dissolves the mixture in a solution, wherein the mixture includes a tetracarboxylic dianhydride component (a) and a diamine component (b), and performs a polymerization reaction to form a polyimide polymer. Then, in the presence of a dehydrating agent and a catalyst, further heating is performed and a dehydration ring-closing reaction is performed, so that the amide functional group in the polyimide polymer is converted into an imide functional group (i.e., imidization) through a dehydration ring-closing reaction, and a polyimide polymer is obtained.

用於脫水閉環反應中之溶劑可與下述液晶配向劑中的溶劑相同,故不另贅述。基於聚醯胺酸聚合物的使用量為100重量份,用於脫水閉環反應中的溶劑的使用量較佳為200重量份至2000重量份,更佳為300重量份至1800重量份。 The solvent used in the dehydration ring-closing reaction can be the same as the solvent in the liquid crystal alignment agent described below, so it is not described separately. Based on the usage of 100 parts by weight of the polyamine polymer, the usage of the solvent used in the dehydration ring-closing reaction is preferably 200 parts by weight to 2000 parts by weight, and more preferably 300 parts by weight to 1800 parts by weight.

為獲得較佳之聚醯胺酸聚合物的醯亞胺化程度,脫水閉環反應的操作溫度較佳為40℃至200℃,更佳為40℃至150℃。若脫水閉環反應的操作溫度低於40℃時,醯亞胺化之反應不完全,而降低聚醯胺酸聚合物的醯亞胺化程度。然而,若脫水閉環反應的操作溫度高於200℃時,所得的聚醯亞胺聚合物的重量平均分子量偏低。 In order to obtain a better degree of imidization of the polyamide polymer, the operating temperature of the dehydration ring-closing reaction is preferably 40°C to 200°C, and more preferably 40°C to 150°C. If the operating temperature of the dehydration ring-closing reaction is lower than 40°C, the imidization reaction is incomplete, thereby reducing the degree of imidization of the polyamide polymer. However, if the operating temperature of the dehydration ring-closing reaction is higher than 200°C, the weight average molecular weight of the obtained polyimide polymer is low.

用於脫水閉環反應中的脫水劑可選自於酸酐類化合物,其具體例如:醋酸酐、丙酸酐或三氟醋酸酐等之酸酐類化合物。基於聚醯胺酸聚合物為1莫耳,脫水劑的使用量為0.01莫耳至20莫耳。用於脫水閉環反應中的觸媒可選自於(1)吡啶類化合物,例如:吡啶、三甲基吡啶或二甲基吡啶等之吡啶類化合物;(2)三級胺類化合物,例如:三乙基胺等之三級胺類化合物。基於脫水劑的使用量為1莫耳,觸媒的使用量為0.5莫耳至10莫耳。 The dehydrating agent used in the dehydration ring-closing reaction can be selected from anhydride compounds, such as acetic anhydride, propionic anhydride or trifluoroacetic anhydride. Based on 1 mol of polyamide polymer, the amount of the dehydrating agent used is 0.01 mol to 20 mol. The catalyst used in the dehydration ring-closing reaction can be selected from (1) pyridine compounds, such as pyridine, trimethylpyridine or dimethylpyridine; (2) tertiary amine compounds, such as triethylamine. Based on 1 mol of the dehydrating agent, the amount of the catalyst used is 0.5 mol to 10 mol.

本發明之聚醯亞胺系嵌段共聚合物之較佳具體例為聚醯胺酸嵌段共聚合物、聚醯亞胺嵌段共聚合物、聚醯胺酸-聚醯亞胺嵌段共聚合物,或其任意組合。 Preferred examples of the polyimide block copolymers of the present invention are polyamic acid block copolymers, polyimide block copolymers, polyamic acid-polyimide block copolymers, or any combination thereof.

本發明之聚醯亞胺系嵌段共聚合物之製備可為一般之方法,較佳地,聚醯亞胺系嵌段共聚合物之製備方法 先將起始物溶解於溶劑中,並進行聚縮合反應,其中所述起始物包含上述之至少一種聚醯胺酸聚合物及/或上述之至少一種聚醯亞胺聚合物,且可進一步地包含四羧酸二酐組份(a)及二胺組份(b)。 The preparation of the polyimide block copolymer of the present invention can be a general method. Preferably, the preparation method of the polyimide block copolymer is to first dissolve the starting material in a solvent and perform a polycondensation reaction, wherein the starting material comprises at least one polyamic acid polymer and/or at least one polyimide polymer as described above, and may further comprise a tetracarboxylic dianhydride component (a) and a diamine component (b).

前述起始物中之四羧酸二酐組份(a)與二胺組份(b)是與上述製備聚醯胺酸聚合物中所使用的四羧酸二酐組份(a)與二胺組份(b)相同,且用於聚縮合反應中的溶劑可與下述液晶配向劑中的溶劑相同,在此不另贅述。 The tetracarboxylic dianhydride component (a) and the diamine component (b) in the aforementioned starting materials are the same as the tetracarboxylic dianhydride component (a) and the diamine component (b) used in the preparation of the polyamide polymer, and the solvent used in the polycondensation reaction can be the same as the solvent in the liquid crystal alignment agent described below, which will not be described in detail here.

基於前述起始物的使用量為100重量份,用於聚縮合反應中之溶劑的使用量較佳為200重量份至2000重量份,更佳為300重量份至1800重量份。聚縮合反應的操作溫度較佳為0℃至200℃,且更佳為0℃至100℃。 Based on the usage of 100 parts by weight of the aforementioned starting material, the usage of the solvent in the polycondensation reaction is preferably 200 parts by weight to 2000 parts by weight, more preferably 300 parts by weight to 1800 parts by weight. The operating temperature of the polycondensation reaction is preferably 0°C to 200°C, and more preferably 0°C to 100°C.

較佳地,起始物包含但不限於(1)二種末端基相異且結構相異之聚醯胺酸聚合物;(2)二種末端基相異且結構相異之聚醯亞胺聚合物;(3)末端基相異且結構相異之聚醯胺酸聚合物及聚醯亞胺聚合物;(4)聚醯胺酸聚合物、四羧酸二酐化合物及二胺化合物,其中,四羧酸二酐化合物及二胺化合物之中的至少一種與形成聚醯胺酸聚合物所使用的四羧酸二酐組份(a)及二胺組份(b)的結構相異;(5)聚醯亞胺聚合物、四羧酸二酐化合物及二胺化合物,其中,所述四羧酸二酐化合物及二胺化合物中的至少一種與形成聚醯亞胺聚合物所使用的四羧酸二酐組份(a)及二胺組份(b)的結構相異;(6)聚醯胺酸聚合物、聚醯亞胺聚合物、四羧酸二酐化合物及二胺化合物,其中,四羧酸二酐化合 物及二胺中的至少一種與形成聚醯胺酸聚合物或聚醯亞胺聚合物所使用的四羧酸二酐組份(a)及二胺組份(b)的結構相異;(7)二種結構相異之聚醯胺酸聚合物、四羧酸二酐化合物及二胺化合物;(8)二種結構相異之聚醯亞胺聚合物、四羧酸二酐化合物及二胺化合物;(9)二種末端基為酸酐基且結構相異的聚醯胺酸聚合物以及二胺化合物;(10)二種末端基為胺基且結構相異的聚醯胺酸聚合物以及四羧酸二酐化合物;(11)二種末端基為酸酐基且結構相異的聚醯亞胺聚合物以及二胺化合物;(12)二種末端基為胺基且結構相異的聚醯亞胺聚合物以及四羧酸二酐化合物。 Preferably, the starting materials include but are not limited to (1) two polyamic acid polymers with different terminal groups and different structures; (2) two polyimide polymers with different terminal groups and different structures; (3) polyamic acid polymers and polyimide polymers with different terminal groups and different structures; (4) polyamic acid polymers, tetracarboxylic dianhydride compounds and diamine compounds, wherein at least one of the tetracarboxylic dianhydride compounds and the diamine compounds is oxidized to form (5) a polyimide polymer, a tetracarboxylic dianhydride compound and a diamine compound, wherein at least one of the tetracarboxylic dianhydride compound and the diamine compound has a structure different from that of the tetracarboxylic dianhydride component (a) and the diamine component (b) used to form the polyimide polymer; (6) a polyimide polymer, a polyimide polymer, A tetracarboxylic dianhydride compound and a diamine compound, wherein at least one of the tetracarboxylic dianhydride compound and the diamine has a structure different from that of the tetracarboxylic dianhydride component (a) and the diamine component (b) used to form the polyamic acid polymer or the polyimide polymer; (7) two polyamic acid polymers, tetracarboxylic dianhydride compounds and diamine compounds having different structures; (8) two polyimide polymers, tetracarboxylic dianhydride compounds and diamine compounds having different structures Compounds; (9) two polyamic acid polymers with different structures and an anhydride group at the end and a diamine compound; (10) two polyamic acid polymers with different structures and an amine group at the end and a tetracarboxylic dianhydride compound; (11) two polyimide polymers with different structures and an anhydride group at the end and a diamine compound; (12) two polyimide polymers with different structures and an amine group at the end and a tetracarboxylic dianhydride compound.

在不影響本發明之功效範圍內,較佳地,前述聚醯胺酸聚合物、前述聚醯亞胺聚合物以及前述聚醯亞胺系嵌段共聚合物可以是先進行分子量調節後的末端修飾型聚合物。藉由使用末端修飾型的聚合物,可改善液晶配向劑的塗佈性能。製備前述末端修飾型聚合物的方式可藉由在聚醯胺酸聚合物進行聚縮合反應的同時,加入單官能性化合物來製得,單官能性化合物包含但不限於(1)一元酸酐,例如:馬來酸酐、鄰苯二甲酸酐、衣康酸酐、正癸基琥珀酸酐、正十二烷基琥珀酸酐、正十四烷基琥珀酸酐或正十六烷基琥珀酸酐等之一元酸酐;(2)單胺化合物,例如:苯胺、環己胺、正丁胺、正戊胺、正己胺、正庚胺、正辛胺、正壬胺、正癸胺、正十一烷胺、正十二烷胺、正十三烷胺、正十四烷胺、正十五烷胺、正十六烷胺、正十七烷胺、正十八烷胺或正二十烷胺等之單胺化合物;(3)單異氰酸酯化 合物,例如:異氰酸苯酯或異氰酸萘基酯等之單異氰酸酯化合物。 Without affecting the efficacy of the present invention, preferably, the aforementioned polyamic acid polymer, the aforementioned polyimide polymer and the aforementioned polyimide-based block copolymer can be terminal-modified polymers after molecular weight adjustment. By using terminal-modified polymers, the coating performance of the liquid crystal alignment agent can be improved. The method for preparing the aforementioned terminal-modified polymer can be prepared by adding a monofunctional compound to the polyamic acid polymer during the polycondensation reaction. The monofunctional compound includes but is not limited to (1) monobasic acid anhydrides, such as maleic anhydride, phthalic anhydride, itaconic anhydride, n-decylsuccinic anhydride, n-dodecylsuccinic anhydride, n-tetradecylsuccinic anhydride or n-hexadecylsuccinic anhydride; (2) monoamine (3) Monoisocyanate compounds, for example, monoamine compounds such as aniline, cyclohexylamine, n-butylamine, n-pentylamine, n-hexylamine, n-heptylamine, n-octylamine, n-nonylamine, n-decylamine, n-undecylamine, n-dodecylamine, n-tridecylamine, n-tetradecylamine, n-pentadecylamine, n-hexadecylamine, n-heptadecylamine, n-octadecylamine or n-eicosylamine; (4) Monoisocyanate compounds, for example, monoisocyanate compounds such as phenyl isocyanate or naphthyl isocyanate.

本發明的聚合物(A)根據凝膠滲透色層分析法所測得經聚苯乙烯換算的重量平均分子量為10,000至90,000,較佳為12,000至75,000,且更佳為15,000至60,000。 The polymer (A) of the present invention has a weight average molecular weight of 10,000 to 90,000, preferably 12,000 to 75,000, and more preferably 15,000 to 60,000, as measured by gel permeation chromatography in terms of polystyrene.

溶劑(B) Solvent (B)

本發明的液晶配向劑中所使用的溶劑並無特別的限制,只要是可溶解聚合物(A)與其他任意成份,且不與其產生反應即可,較佳為同前述合成聚醯胺酸中所使用的溶劑,同時,亦可併用合成前述聚醯胺酸時所使用的貧溶劑。 There is no particular limitation on the solvent used in the liquid crystal alignment agent of the present invention, as long as it can dissolve the polymer (A) and any other components and does not react with them. It is preferably the same solvent used in the aforementioned synthesis of polyamine. At the same time, the poor solvent used in the synthesis of the aforementioned polyamine can also be used in combination.

溶劑(B)的具體例包含但不限於N-甲基-2-吡咯烷酮(NMP)、γ-丁內酯、γ-丁內醯胺、4-羥基-4-甲基-2-戊酮、乙二醇單甲基醚、乳酸丁酯、乙酸丁酯、甲氧基丙酸甲酯、乙氧基丙酸乙酯、乙二醇甲基醚、乙二醇乙基醚、乙二醇正丙基醚、乙二醇異丙基醚、乙二醇正丁基醚(ethylene glycol n-butyl ether)、乙二醇二甲基醚、乙二醇乙基醚乙酸酯、二乙二醇二甲基醚、二乙二醇二乙基醚、二乙二醇單甲基醚、二乙二醇單乙基醚、二乙二醇單甲基醚乙酸酯、二乙二醇單乙基醚乙酸酯或N,N-二甲基甲醯胺或N,N-二甲基乙醯胺(N,N-dimethyl acetamide)等。 Specific examples of the solvent (B) include but are not limited to N-methyl-2-pyrrolidone (NMP), γ-butyrolactone, γ-butyrolactamide, 4-hydroxy-4-methyl-2-pentanone, ethylene glycol monomethyl ether, butyl lactate, butyl acetate, methyl methoxypropionate, ethyl ethoxypropionate, ethylene glycol methyl ether, ethylene glycol ethyl ether, ethylene glycol n-propyl ether, ethylene glycol isopropyl ether, ethylene glycol n-butyl ether, ethylene glycol dimethyl ether, ethylene glycol ethyl ether acetate, diethylene glycol dimethyl ether, diethylene glycol diethyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monomethyl ether acetate, diethylene glycol monoethyl ether acetate or N,N-dimethylformamide or N,N-dimethylacetamide, etc.

前述之溶劑(B)可單獨一種使用或混合複數種使用。 The aforementioned solvent (B) can be used alone or in combination of two or more.

基於聚合物(A)的使用量為100重量份,溶劑(B)的使用量為800重量份至4000重量份,較佳為900重量份至3500重量份,且更佳為1000至3000重量份。 Based on the usage of polymer (A) being 100 parts by weight, the usage of solvent (B) is 800 to 4000 parts by weight, preferably 900 to 3500 parts by weight, and more preferably 1000 to 3000 parts by weight.

添加劑(C) Additives (C)

在不影響本發明之功效範圍內,本發明之液晶配向劑可選擇性地包含添加劑(C),且添加劑(C)可為環氧化合物或具有官能性基團之矽烷化合物等。添加劑(C)的作用是用來提高前述液晶配向膜與基板表面的附著性。添加劑(C)可以單獨一種使用或者混合複數種使用。 Within the scope of not affecting the efficacy of the present invention, the liquid crystal alignment agent of the present invention may optionally include an additive (C), and the additive (C) may be an epoxy compound or a silane compound with a functional group. The function of the additive (C) is to improve the adhesion between the aforementioned liquid crystal alignment film and the substrate surface. The additive (C) can be used alone or in combination.

前述之環氧化合物可包含但不限於乙二醇二環氧丙基醚、聚乙二醇二環氧丙基醚、丙二醇二環氧丙基醚、三丙二醇二環氧丙基醚、聚丙二醇二環氧丙基醚、新戊二醇二環氧丙基醚、1,6-己二醇二環氧丙基醚、丙三醇二環氧丙基醚、2,2-二溴新戊二醇二環氧丙基醚、1,3,5,6-四環氧丙基-2,4-己二醇、N,N,N',N'-四環氧丙基-間-二甲苯二胺、1,3-雙(N,N-二環氧丙基胺基甲基)環己烷、N,N,N',N'-四環氧丙基-4,4'-二胺基二苯基甲烷、N,N-環氧丙基-對-環氧丙氧基苯胺、3-(N-烯丙基-N-環氧丙基)胺基丙基三甲氧基矽烷、3-(N,N-二環氧丙基)胺基丙基三甲氧基矽烷等。 The epoxy compound mentioned above may include but is not limited to ethylene glycol diglycidyl ether, polyethylene glycol diglycidyl ether, propylene glycol diglycidyl ether, tripropylene glycol diglycidyl ether, polypropylene glycol diglycidyl ether, neopentyl glycol diglycidyl ether, 1,6-hexanediol diglycidyl ether, glycerol diglycidyl ether, 2,2-dibromoneopentyl glycol diglycidyl ether, 1,3,5,6-tetraglycidyl-2,4-hexanediol, N,N, N',N'-tetracycloxypropyl-m-xylene diamine, 1,3-bis(N,N-dicycloxypropylaminomethyl)cyclohexane, N,N,N',N'-tetracycloxypropyl-4,4'-diaminodiphenylmethane, N,N-cycloxypropyl-p-cycloxypropyloxyaniline, 3-(N-allyl-N-cycloxypropyl)aminopropyltrimethoxysilane, 3-(N,N-dicycloxypropyl)aminopropyltrimethoxysilane, etc.

基於聚合物(A)的使用量為100重量份,環氧化合物的使用量一般為40重量份以下,且較佳為0.1重量份至30重量份。 Based on the usage of polymer (A) being 100 parts by weight, the usage of epoxy compound is generally less than 40 parts by weight, and preferably 0.1 parts by weight to 30 parts by weight.

上述具有官能性基團之矽烷化合物可包含但不限 於3-胺基丙基三甲氧基矽烷、3-胺基丙基三乙氧基矽烷、2-胺基丙基三甲氧基矽烷、2-胺基丙基三乙氧基矽烷、N-(2-胺基乙基)-3-胺基丙基三甲氧基矽烷、N-(2-胺基乙基)-3-胺基丙基甲基二甲氧基矽烷、3-脲基丙基三甲氧基矽烷(3-ureidopropyltrimethoxysilane)、3-脲基丙基三乙氧基矽烷、N-乙氧基羰基-3-胺基丙基三甲氧基矽烷、N-乙氧基羰基-3-胺基丙基三乙氧基矽烷、N-三乙氧基矽烷基丙基三伸乙三胺、N-三甲氧基矽烷基丙基三伸乙三胺、10-三甲氧基矽烷基-1,4,7-三吖癸烷、10-三乙氧基矽烷基-1,4,7-三吖癸烷、9-三甲氧基矽烷基-3,6-二吖壬基醋酸酯、9-三乙氧基矽烷基-3,6-二吖壬基醋酸酯、N-苯甲基-3-胺基丙基三甲氧基矽烷、N-苯甲基-3-胺基丙基三乙氧基矽烷、N-苯基-3-胺基丙基三甲氧基矽烷、N-苯基-3-胺基丙基三乙氧基矽烷、N-雙(氧化乙烯)-3-胺基丙基三甲氧基矽烷、N-雙(氧化乙烯)-3-胺基丙基三乙氧基矽烷等。 The silane compound having a functional group may include but is not limited to 3-aminopropyltrimethoxysilane, 3-aminopropyltriethoxysilane, 2-aminopropyltrimethoxysilane, 2-aminopropyltriethoxysilane, N-(2-aminoethyl)-3-aminopropyltrimethoxysilane, N-(2-aminoethyl)-3-aminopropylmethyldimethoxysilane, 3-ureidopropyltrimethoxysilane, 3-ureidopropyltriethoxysilane, N-ethoxycarbonyl-3-aminopropyltrimethoxysilane, N-ethoxycarbonyl-3-aminopropyltriethoxysilane, N-triethoxysilane Propyl triethylenetriamine, N-trimethoxysilylpropyl triethylenetriamine, 10-trimethoxysilyl-1,4,7-triazdecane, 10-triethoxysilyl-1,4,7-triazdecane, 9-trimethoxysilyl-3,6-diazononyl acetate, 9-triethoxysilyl-3,6-diazononyl acetate, N-benzyl-3-aminopropyl trimethoxysilane, N-benzyl-3-aminopropyl triethoxysilane, N-phenyl-3-aminopropyl trimethoxysilane, N-phenyl-3-aminopropyl triethoxysilane, N-bis(ethylene oxide)-3-aminopropyl trimethoxysilane, N-bis(ethylene oxide)-3-aminopropyl triethoxysilane, etc.

基於聚合物(A)的使用量為100重量份,矽烷化合物的使用量一般為10重量份以下,且較佳為0.5重量份至10重量份。 Based on the usage of polymer (A) being 100 parts by weight, the usage of silane compound is generally less than 10 parts by weight, and preferably 0.5 parts by weight to 10 parts by weight.

基於聚合物(A)的使用量為100重量份,添加劑(C)的使用量可為0.5重量份至50重量份,且較佳為1重量份至45重量份。 Based on the usage of polymer (A) being 100 parts by weight, the usage of additive (C) can be 0.5 parts by weight to 50 parts by weight, and preferably 1 part by weight to 45 parts by weight.

液晶配向劑的製備方法 Preparation method of liquid crystal alignment agent

本發明之液晶配向劑之製備方法並無特別之限制, 可採用一般之混合方法,如先將四羧酸二酐組份(a)及二胺組份(b)混合均勻,以反應形成聚合物(A)。接著,將聚合物(A)於溫度為0℃至200℃的條件下加入溶劑(B)和添加劑(C),以攪拌裝置持續攪拌至溶解即可。較佳地,於20℃至60℃的溫度下,將聚合物(A)和添加劑(C)加入溶劑(B)。 The preparation method of the liquid crystal alignment agent of the present invention is not particularly limited. General mixing methods can be used, such as first mixing the tetracarboxylic dianhydride component (a) and the diamine component (b) evenly to react and form a polymer (A). Then, the polymer (A) is added with a solvent (B) and an additive (C) at a temperature of 0°C to 200°C, and stirred continuously with a stirring device until dissolved. Preferably, the polymer (A) and the additive (C) are added to the solvent (B) at a temperature of 20°C to 60°C.

液晶配向膜的形成方法 Method for forming liquid crystal alignment film

本發明之液晶配向膜是將上述所形成的液晶配向劑塗佈於基板上,並經乾燥和烘烤而製得的膜。 The liquid crystal alignment film of the present invention is a film obtained by coating the liquid crystal alignment agent formed above on a substrate, and then drying and baking.

本發明之液晶配向劑所塗佈的基板選自於透明材料,其中,透明材料包含但不限於用於液晶顯示裝置的無鹼玻璃、鈉鈣玻璃、硬質玻璃(派勒斯玻璃)、石英玻璃、聚乙烯對苯二甲酸酯、聚丁烯對苯二甲酸酯、聚醚碸、聚碳酸酯等,較佳可使用液晶驅動用的ITO電極已形成於基板上者,以簡化製程。再者,對只有單側基板的反射型液晶顯示器而言,前述基板可使用矽晶圓等不透明的材質,在這種情況下的電極可使用鋁等會反射光的材料來形成。本發明之液晶配向劑的塗佈方法可例如旋轉塗佈法、印刷法、噴墨法等。 The substrate on which the liquid crystal alignment agent of the present invention is applied is selected from transparent materials, wherein the transparent materials include but are not limited to alkali-free glass, sodium calcium glass, hard glass (Pyles glass), quartz glass, polyethylene terephthalate, polybutylene terephthalate, polyether sulfide, polycarbonate, etc. used in liquid crystal display devices. It is preferred to use the ITO electrode for liquid crystal driving that has been formed on the substrate to simplify the process. Furthermore, for a reflective liquid crystal display with only a single-sided substrate, the aforementioned substrate can use an opaque material such as a silicon wafer. In this case, the electrode can be formed using a material that reflects light such as aluminum. The coating method of the liquid crystal alignment agent of the present invention can be, for example, a spin coating method, a printing method, an inkjet method, etc.

本發明的液晶配向劑可選擇任意的溫度和時間,進行塗佈後的乾燥和烘烤製程。一般而言,為充分去除所含的有機溶劑,需在50℃至120℃下進行1分鐘至10分鐘的乾燥。之後,在150℃至300℃下進行5分鐘至120分鐘的烘烤。烘烤後的塗膜厚度並未有特別限制,但過薄的 塗膜會造成液晶顯示器的可信賴度劣化,故上述塗膜厚度以5nm至300nm為宜,又以10nm至200nm為較佳。 The liquid crystal alignment agent of the present invention can be dried and baked at any temperature and time after coating. Generally speaking, in order to fully remove the organic solvent contained, it is necessary to dry at 50°C to 120°C for 1 minute to 10 minutes. After that, it is baked at 150°C to 300°C for 5 minutes to 120 minutes. There is no special restriction on the thickness of the coating after baking, but too thin coating will cause the reliability of the liquid crystal display to deteriorate, so the thickness of the above coating is preferably 5nm to 300nm, and 10nm to 200nm is more preferred.

本發明之液晶配向劑雖然可進行習知的摩擦定向處理,但在使用光配向處理法的情況時效果更佳。 Although the liquid crystal alignment agent of the present invention can be subjected to the known rubbing alignment treatment, the effect is better when using the photoalignment treatment method.

光配向處理法的具體例可例如:將前述塗膜的表面,以朝特定方向偏光的放射線照射,然後視情況在150℃至250℃的溫度下進行加熱處理,以賦予上述塗膜液晶配向能。其中,可使用具有100nm至800nm之波長的紫外線或可見光做為上述放射線,又以波長為100nm至400nm的紫外線較佳,而以波長為200nm至400nm者為更佳。再者,為了改善液晶配向性,可在50℃至250℃下加熱塗膜基板的同時,以放射線照射塗膜基板。前述放射線的照射量較佳為1mJ/cm2至10,000mJ/cm2,又以100mJ/cm2至5,000mJ/cm2為更佳。按照上述方式製得的液晶配向膜,可使液晶分子以一定方向穩定地被配向。 A specific example of the photo-alignment treatment method may be, for example, irradiating the surface of the aforementioned coating with radiation polarized in a specific direction, and then heating it at a temperature of 150°C to 250°C as appropriate to give the aforementioned coating liquid crystal alignment ability. Among them, ultraviolet light or visible light with a wavelength of 100nm to 800nm can be used as the aforementioned radiation, and ultraviolet light with a wavelength of 100nm to 400nm is preferred, and ultraviolet light with a wavelength of 200nm to 400nm is more preferred. Furthermore, in order to improve the liquid crystal alignment, the coated substrate may be irradiated with radiation while heating the coated substrate at 50°C to 250°C. The radiation dose is preferably 1 mJ/cm 2 to 10,000 mJ/cm 2 , and more preferably 100 mJ/cm 2 to 5,000 mJ/cm 2 . The liquid crystal alignment film prepared in the above manner can align liquid crystal molecules stably in a certain direction.

本發明的液晶配向劑經預烤處理、後烤處理及光配向處理後而形成液晶配向膜,前述液晶配向膜之預傾角為0°至3°。 The liquid crystal alignment agent of the present invention is subjected to pre-baking, post-baking and photo-alignment treatment to form a liquid crystal alignment film, and the pre-tilt angle of the liquid crystal alignment film is 0° to 3°.

液晶顯示元件的製造方法 Manufacturing method of liquid crystal display element

本發明又提供一種液晶顯示元件,其包含前述之液晶配向膜。 The present invention also provides a liquid crystal display element, which includes the aforementioned liquid crystal alignment film.

液晶顯示元件之製作方式為本技術領域者所周知, 因此,以下僅簡單地進行陳述。 The manufacturing method of liquid crystal display elements is well known to those in the art, so the following is only briefly described.

參閱圖1,本發明液晶顯示元件100之較佳實施例包含第一單元110、第二單元120及液晶單元130,其中第二單元120與第一單元110間隔相對,且液晶單元130設置在第一單元110與第二單元120之間。 Referring to FIG. 1 , a preferred embodiment of the liquid crystal display element 100 of the present invention includes a first unit 110, a second unit 120, and a liquid crystal unit 130, wherein the second unit 120 is spaced opposite to the first unit 110, and the liquid crystal unit 130 is disposed between the first unit 110 and the second unit 120.

第一單元110包含第一基板112、電極114及第一液晶配向膜116,其中電極114以櫛齒型圖案化的方式形成於第一基板112之表面,且第一液晶配向膜116形成在電極114之表面。 The first unit 110 includes a first substrate 112, an electrode 114 and a first liquid crystal alignment film 116, wherein the electrode 114 is formed on the surface of the first substrate 112 in a serrated pattern, and the first liquid crystal alignment film 116 is formed on the surface of the electrode 114.

第二單元120包含第二基板122及第二液晶配向膜126,其中第二液晶配向膜126形成在第二基板122的表面。 The second unit 120 includes a second substrate 122 and a second liquid crystal alignment film 126, wherein the second liquid crystal alignment film 126 is formed on the surface of the second substrate 122.

第一基板112與第二基板122是選自於透明材料等,其中,透明材料包含但不限於用於液晶顯示裝置的無鹼玻璃、鈉鈣玻璃、硬質玻璃(派勒斯玻璃)、石英玻璃、聚乙烯對苯二甲酸酯、聚丁烯對苯二甲酸酯、聚醚碸、聚碳酸酯等。電極114的材質是擇自於氧化錫(SnO2)、氧化銦-氧化錫(In2O3-SnO2)等的透明電極;或鉻等金屬電極。 The first substrate 112 and the second substrate 122 are selected from transparent materials, wherein the transparent materials include but are not limited to alkali-free glass, sodium calcium glass, hard glass (Pyles glass), quartz glass, polyethylene terephthalate, polybutylene terephthalate, polyether sulfide, polycarbonate, etc. used in liquid crystal display devices. The material of the electrode 114 is selected from transparent electrodes such as tin oxide (SnO 2 ), indium oxide-tin oxide (In 2 O 3 -SnO 2 ) or metal electrodes such as chromium.

第一液晶配向膜116及第二液晶配向膜126分別為上述之液晶配向膜,其作用在於使液晶單元130形成預傾角,且液晶單元130可被電極114產生的平行電場驅動。 The first liquid crystal alignment film 116 and the second liquid crystal alignment film 126 are the above-mentioned liquid crystal alignment films, which function to form a pre-tilt angle for the liquid crystal unit 130, and the liquid crystal unit 130 can be driven by the parallel electric field generated by the electrode 114.

液晶單元130所使用的液晶可單獨或混合複數種 使用,液晶包含但不限於二胺基苯類液晶、噠嗪(pyridazine)類液晶、希夫氏鹼(shiff base)類液晶、氧化偶氮基(azoxy)類液晶、聯苯類液晶、苯基環己烷類液晶、聯苯(biphenyl)類液晶、苯基環己烷(phenylcyclohexane)類液晶、酯(ester)類液晶、三聯苯(terphenyl)、聯苯環己烷(biphenylcyclohexane)類液晶、嘧啶(pyrimidine)類液晶、二氧六環(dioxane)類液晶、雙環辛烷(bicyclooctane)類液晶、立方烷(cubane)類液晶等,且可視需求再添加如氯化膽固醇(cholesteryl chloride)、膽固醇壬酸酯(cholesteryl nonanoate)、膽固醇碳酸酯(cholesteryl carbonate)等的膽固醇型液晶,或是以商品名為「C-15」、「CB-15」(默克公司製造)的對掌(chiral)劑等,或者對癸氧基苯亞甲基-對胺基-2-甲基丁基肉桂酸酯等強誘電性(ferroelectric)類液晶。 The liquid crystal used in the liquid crystal unit 130 can be used alone or in combination. The liquid crystal includes but is not limited to diaminobenzene liquid crystal, pyridazine liquid crystal, shiff base liquid crystal, azoxy liquid crystal, biphenyl liquid crystal, phenylcyclohexane liquid crystal, biphenyl liquid crystal, phenylcyclohexane liquid crystal, ester liquid crystal, terphenyl, biphenylcyclohexane liquid crystal, pyrimidine liquid crystal, dioxane liquid crystal, bicyclooctane liquid crystal, cubane liquid crystal, etc., and cholesterol chloride, cholesterol nonanoate, cholesterol carbonate, etc. can be added as needed. carbonate), or chiral agents such as "C-15" and "CB-15" (Merck), or ferroelectric liquid crystals such as p-decyloxybenzylidene-p-amino-2-methylbutylcinnamate.

本發明的液晶配向劑所製作之液晶顯示元件適用於各式向列液晶,如TN、STN、TFT、VA、IPS等之液晶顯示元件。此外,根據所選擇的液晶,亦可使用於強誘電性或反強誘電性等不同的液晶顯示元件。上述液晶顯示元件中,特別適用於IPS型之液晶顯示元件。 The liquid crystal display element made by the liquid crystal alignment agent of the present invention is suitable for various nematic liquid crystals, such as TN, STN, TFT, VA, IPS and other liquid crystal display elements. In addition, according to the selected liquid crystal, it can also be used for different liquid crystal display elements such as strong induction or anti-strong induction. Among the above-mentioned liquid crystal display elements, it is particularly suitable for IPS type liquid crystal display elements.

以下利用實施例以說明本發明之應用,然其並非用以限定本發明,任何熟習此技藝者,在不脫離本發明之精神和範圍內,當可作各種之更動與潤飾。 The following examples are used to illustrate the application of the present invention, but they are not used to limit the present invention. Anyone familiar with this technology can make various changes and modifications without departing from the spirit and scope of the present invention.

100:液晶顯示元件 100: Liquid crystal display element

110:第一單元 110: Unit 1

112:第一基板 112: First substrate

114:電極 114: Electrode

116:第一液晶配向膜 116: First liquid crystal alignment film

120:第二單元 120: Unit 2

122:第二基板 122: Second substrate

126:第二液晶配向膜 126: Second liquid crystal alignment film

130:液晶單元 130: Liquid crystal unit

為了對本發明之實施例及其優點有更完整之理解,現請參照以下之說明並配合相應之圖式。必須強調的是,各種特徵並非依比例描繪且僅係為了圖解目的。相關圖式內容說明如下:圖1係繪示根據本發明之一實施例所述之液晶顯示元件的結構示意圖。 In order to have a more complete understanding of the embodiments of the present invention and its advantages, please refer to the following description and the corresponding drawings. It must be emphasized that the various features are not drawn to scale and are only for illustration purposes. The contents of the relevant drawings are described as follows: Figure 1 is a schematic diagram of the structure of a liquid crystal display element according to one embodiment of the present invention.

製備聚合物(A-1) Preparation of polymer (A-1)

合成例A-1-1 Synthesis Example A-1-1

在一容積500毫升之四頸錐瓶上設置氮氣入口、攪拌器、冷凝管及溫度計,並導入氮氣。然後,加入0.87克(0.0025莫耳)的如式(II-2-12)所示之二胺化合物(b-1-4)、0.235克(0.0005莫耳)的如式(IV-3)所示之二胺化合物(b-2-1)與5.076克(0.047莫耳)的對-二胺苯(b-3-1)及80克的N-甲基-2-吡咯烷酮(以下簡稱NMP),並於室溫下攪拌至溶解。接著,加入11.2克(0.05莫耳)的如式(I-1)所示的化合物(a-1-1)及20克的NMP,並於室溫下反應2小時。反應結束後,將反應溶液倒入1500毫升的水中,以析出聚合物,過濾所得之聚合物,並以甲醇重複進行清洗及過濾之步驟三次。之後,將產物置入真空烘箱中,並以溫度60℃進行乾燥,即可製得合成例 A-1-1之聚合物(A-1-1),其配方如第1表所示。 A nitrogen inlet, a stirrer, a condenser and a thermometer were installed on a 500 ml four-necked conical flask, and nitrogen was introduced. Then, 0.87 g (0.0025 mol) of the diamine compound (b-1-4) represented by formula (II-2-12), 0.235 g (0.0005 mol) of the diamine compound (b-2-1) represented by formula (IV-3), 5.076 g (0.047 mol) of p-diaminobenzene (b-3-1) and 80 g of N-methyl-2-pyrrolidone (hereinafter referred to as NMP) were added, and stirred at room temperature until dissolved. Then, 11.2 g (0.05 mol) of the compound (a-1-1) represented by formula (I-1) and 20 g of NMP were added, and the mixture was reacted at room temperature for 2 hours. After the reaction is completed, the reaction solution is poured into 1500 ml of water to precipitate the polymer, and the obtained polymer is filtered and washed and filtered with methanol three times. After that, the product is placed in a vacuum oven and dried at a temperature of 60°C to obtain the polymer (A-1-1) of Synthesis Example A-1-1, whose formula is shown in Table 1.

合成例A-1-2至合成例A-1-15與比較合成例A'-1-1至比較合成例A'-1-4 Synthesis Examples A-1-2 to A-1-15 and Comparative Synthesis Examples A'-1-1 to A'-1-4

合成例A-1-2至合成例A-1-15與比較合成例A'-1-1至比較合成例A'-1-4使用與合成例A-1-1之聚合物(A-1-1)的製作方法相同之製備方法,不同之處在於合成例A-1-2至合成例A-1-15與比較合成例A'-1-1至比較合成例A'-1-4改變聚合物中原料的種類與使用量,其配方如第1表所示,此處不另贅述。 Synthesis Examples A-1-2 to A-1-15 and Comparative Synthesis Examples A'-1-1 to A'-1-4 use the same preparation method as the preparation method of the polymer (A-1-1) of Synthesis Example A-1-1. The difference is that Synthesis Examples A-1-2 to A-1-15 and Comparative Synthesis Examples A'-1-1 to A'-1-4 change the type and amount of raw materials in the polymer. The formula is shown in Table 1 and is not further described here.

製備聚合物(A-2) Preparation of polymer (A-2)

合成例A-2-1 Synthesis Example A-2-1

在一容積500毫升之四頸錐瓶上設置氮氣入口、攪拌器、冷凝管及溫度計,並導入氮氣。然後,加入0.87克(0.0025莫耳)的如式(II-2-12)所示之二胺化合物(b-1-4)、0.235克(0.0005莫耳)的如式(IV-3)所示之二胺化合物(b-2-1)與5.076克(0.047莫耳)的對-二胺苯(b-3-1)及80克的N-甲基-2-吡咯烷酮(以下簡稱NMP),並於室溫下攪拌至溶解。接著,加入11.2克(0.05莫耳)的如式(I-1)所示的化合物(a-1-1)及20克的NMP。於室溫下反應6小時後,加入97克的NMP、2.55克的醋酸酐及19.75克的吡啶,升溫至60℃,且持續攪拌2小時,以進行醯亞胺化反應。待反應結束後,將反應溶液倒入1500毫升水中,以使聚合物析出。然後,過濾所得的聚合物,並重複以甲醇清洗及過濾三次,置入真空烘箱 中,以溫度60℃進行乾燥後,即可得聚合物(A-2-1),其配方如第1表所示。 A nitrogen inlet, a stirrer, a condenser and a thermometer were installed on a 500 ml four-necked conical flask, and nitrogen was introduced. Then, 0.87 g (0.0025 mol) of the diamine compound (b-1-4) represented by formula (II-2-12), 0.235 g (0.0005 mol) of the diamine compound (b-2-1) represented by formula (IV-3), 5.076 g (0.047 mol) of p-diaminobenzene (b-3-1) and 80 g of N-methyl-2-pyrrolidone (hereinafter referred to as NMP) were added, and stirred at room temperature until dissolved. Then, 11.2 g (0.05 mol) of the compound (a-1-1) represented by formula (I-1) and 20 g of NMP were added. After reacting at room temperature for 6 hours, 97 grams of NMP, 2.55 grams of acetic anhydride and 19.75 grams of pyridine were added, the temperature was raised to 60°C, and stirring was continued for 2 hours to carry out the imidization reaction. After the reaction was completed, the reaction solution was poured into 1500 ml of water to precipitate the polymer. Then, the obtained polymer was filtered, and washed and filtered with methanol three times repeatedly, placed in a vacuum oven, and dried at a temperature of 60°C to obtain polymer (A-2-1), whose formula is shown in Table 1.

合成例A-2-2至合成例A-2-5與比較合成例A'-2-1至比較合成例A'-2-3 Synthesis Examples A-2-2 to A-2-5 and Comparative Synthesis Examples A'-2-1 to A'-2-3

合成例A-2-2至合成例A-2-5與比較合成例A'-2-1至比較合成例A'-2-3使用與合成例A-2-1之聚合物(A-2-1)的製作方法相同之製備方法,不同之處在於A-2-2至合成例A-2-5與比較合成例A'-2-1至比較合成例A-2-3改變聚合物中原料的種類與使用量,其配方如第1表所示,此處不另贅述。 Synthesis Examples A-2-2 to A-2-5 and Comparative Synthesis Examples A'-2-1 to A'-2-3 use the same preparation method as the preparation method of the polymer (A-2-1) in Synthesis Example A-2-1. The difference is that the types and usage amounts of raw materials in the polymers are changed in Synthesis Examples A-2-2 to A-2-5 and Comparative Synthesis Examples A'-2-1 to A-2-3. The formula is shown in Table 1 and will not be described here.

Figure 109123631-A0305-02-0056-163
Figure 109123631-A0305-02-0056-163

a-1-1 如式(I-1)所示之化合物 a-1-1 The compound represented by formula (I-1)

a-1-2 如式(I-2)所示之化合物 a-1-2 The compound represented by formula (I-2)

a-1-3 如式(I-3)所示之化合物 a-1-3 The compound represented by formula (I-3)

a-1-4 如式(I-5)所示之化合物 a-1-4 The compound represented by formula (I-5)

a-1-5 如式(I-8)所示之化合物 a-1-5 The compound represented by formula (I-8)

a-2-1 苯均四羧酸二酐(pyromellitic dianhydride) a-2-1 Pyromellitic dianhydride

a-2-2 2,3,5-三羧基環戊基醋酸二酐(2,3,5-tricarboxycyclopentylacetic acid dianhydride) a-2-2 2,3,5-tricarboxycyclopentylacetic acid dianhydride

a-2-3 3,4-二羧基-1,2,3,4-四氫萘-1-琥珀酸二酐(3,4-dicarboxy-1,2,3,4-tetrahydronaphthalene-1-succinic dianhydride) a-2-3 3,4-dicarboxy-1,2,3,4-tetrahydronaphthalene-1-succinic dianhydride

b-1-1 如式(II-2-1)所示之化合物 b-1-1 The compound represented by formula (II-2-1)

b-1-2 如式(II-2-8)所示之化合物 b-1-2 The compound represented by formula (II-2-8)

b-1-3 如式(II-2-11)所示之化合物 b-1-3 The compound represented by formula (II-2-11)

b-1-4 如式(II-2-12)所示之化合物 b-1-4 The compound shown in formula (II-2-12)

b-1-5 如式(II-2-14)所示之化合物 b-1-5 The compound represented by formula (II-2-14)

b-1-6 如式(II-2-18)所示之化合物 b-1-6 The compound shown in formula (II-2-18)

b-1-7 如式(II-2-19)所示之化合物 b-1-7 The compound represented by formula (II-2-19)

b-1-8 如式(II-2-22)所示之化合物 b-1-8 The compound represented by formula (II-2-22)

b-1-9 如式(II-2-27)所示之化合物 b-1-9 The compound shown in formula (II-2-27)

b-1-10 如式(II-2-28)所示之化合物 b-1-10 The compound represented by formula (II-2-28)

b'-1-1

Figure 109123631-A0305-02-0057-220
b'-1-1
Figure 109123631-A0305-02-0057-220

b'-1-2

Figure 109123631-A0305-02-0057-221
b'-1-2
Figure 109123631-A0305-02-0057-221

b'-1-3

Figure 109123631-A0305-02-0057-224
b'-1-3
Figure 109123631-A0305-02-0057-224

b'-1-4

Figure 109123631-A0305-02-0057-225
b'-1-4
Figure 109123631-A0305-02-0057-225

b-2-1 如式(IV-3)所示之化合物 b-2-1 The compound represented by formula (IV-3)

b-2-2 如式(IV-14)所示之化合物 b-2-2 The compound represented by formula (IV-14)

b-2-3 如式(IV-18)所示之化合物 b-2-3 The compound represented by formula (IV-18)

b-2-4 如式(IV-29)所示之化合物 b-2-4 The compound represented by formula (IV-29)

b-2-5 如式(IV-45所示之化合物 b-2-5 The compound shown in formula (IV-45

b-2-6 如式(IV-46)所示之化合物 b-2-6 The compound represented by formula (IV-46)

b-3-1 對-二胺苯(p-diaminobezene) b-3-1 p-diaminobenzene

b-3-2 4,4’-二胺基二苯基甲烷(4,4'-diaminodiphenylmethane) b-3-2 4,4'-diaminodiphenylmethane

b-3-3 1,3-雙(3-胺基苯氧基)苯 b-3-3 1,3-Bis(3-aminophenoxy)benzene

製備液晶配向劑、液晶配向膜及液晶顯示元件 Preparation of liquid crystal alignment agents, liquid crystal alignment films and liquid crystal display elements

實施例1 Implementation Example 1

秤取100重量份之合成例A-1-1所製得的聚合物(A-1-1)與800重量份之NMP(B-1),並於室溫下攪拌混合,即可製得實施例1之液晶配向劑。 Weigh 100 parts by weight of the polymer (A-1-1) prepared in Synthesis Example A-1-1 and 800 parts by weight of NMP (B-1), and stir and mix them at room temperature to prepare the liquid crystal alignment agent of Example 1.

將前述實施例1所製得的液晶配向劑旋轉塗佈在玻璃基板上,且此玻璃基板上具有畫素電極,其中畫素電極為具有一對ITO電極(電極寬:10μm,電極間隔:10μm,電極高度:50nm)之IPS驅動用電極,該對ITO電極係分別具有櫛齒狀之形狀、且彼此之櫛齒狀部份係以分開並咬合之方式來配置。然後,將塗佈有液晶配向劑的玻璃基板在80℃的加熱板上乾燥,經過5分鐘後,在250℃之熱風循環式烘箱中烘烤60分鐘,以形成膜厚為100nm的塗膜。 The liquid crystal alignment agent prepared in the above-mentioned Example 1 is rotationally coated on a glass substrate, and the glass substrate has a pixel electrode, wherein the pixel electrode is an IPS driving electrode having a pair of ITO electrodes (electrode width: 10μm, electrode spacing: 10μm, electrode height: 50nm), and the pair of ITO electrodes are respectively in a comb-shaped shape, and the comb-shaped parts of each other are configured in a separated and interlocking manner. Then, the glass substrate coated with the liquid crystal alignment agent is dried on a heating plate at 80°C, and after 5 minutes, it is baked in a hot air circulation oven at 250°C for 60 minutes to form a coating with a film thickness of 100nm.

透過一偏光板,對塗膜面照射波長為254nm的紫外線,以製得具有液晶配向膜的基板。接著,同樣地,在對向基板上形成塗膜並施予配向處理,所述對向基板為不具有電極但具有高度為4μm之柱狀間隔件的玻璃基板。 Through a polarizing plate, the coated surface is irradiated with ultraviolet light of a wavelength of 254nm to produce a substrate with a liquid crystal alignment film. Then, similarly, a coating is formed on the opposite substrate and an alignment treatment is applied. The opposite substrate is a glass substrate without an electrode but with a columnar spacer with a height of 4μm.

上述二個基板為一組,在其中一者上印刷密封劑,而另一者以與液晶配向膜面對且配向方向為0°的方式來黏合二者。然後,硬化密封劑,以製得空的晶胞。之後,利用減壓注入法將液晶MLC-2041(Merck公司製)注入空晶胞中,並密封注入口,即製得實施例1之液晶顯示元 件。 The two substrates are a set, a sealant is printed on one of them, and the other is bonded in a way that it faces the liquid crystal alignment film and the alignment direction is 0°. Then, the sealant is hardened to produce an empty cell. After that, the liquid crystal MLC-2041 (Merck) is injected into the empty cell by the reduced pressure injection method, and the injection port is sealed to obtain the liquid crystal display element of Example 1.

所得之液晶顯示元件以下列之評價方式進行評價,其結果如第2表所示,其中驅動後即時之閃爍程度的檢測方法容後再述。 The obtained liquid crystal display element was evaluated by the following evaluation method, and the results are shown in Table 2. The method for testing the flicker level immediately after driving will be described later.

實施例2至實施例20與比較例1至比較例7 Examples 2 to 20 and Comparative Examples 1 to 7

實施例2至實施例20與比較例1至比較例7係使用與實施例1之液晶配向劑、液晶配向膜及液晶顯示元件相同之製備方法,不同之處在於實施例2至實施例20與比較例1至比較例7係改變液晶配向劑中原料的種類及使用量,其配方及評價結果分別如第2與3表所示,此處不另贅述。 Examples 2 to 20 and Comparative Examples 1 to 7 use the same preparation method of the liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element as Example 1. The difference is that Examples 2 to 20 and Comparative Examples 1 to 7 change the type and amount of raw materials in the liquid crystal alignment agent. The formula and evaluation results are shown in Tables 2 and 3 respectively, and will not be described here.

Figure 109123631-A0305-02-0059-164
Figure 109123631-A0305-02-0059-164

Figure 109123631-A0305-02-0060-165
Figure 109123631-A0305-02-0060-165

於第3表中,B-1、B-2、B-3、C-1與C-2之種類如第2表所述,在此不另贅述。 In Table 3, the types of B-1, B-2, B-3, C-1 and C-2 are as described in Table 2 and will not be further described here.

評價方式 Evaluation method

驅動後即時之閃爍程度 The flashing degree immediately after driving

將所製得之液晶顯示元件設置於偏光軸以垂直交叉方式配置的兩片偏光板之間,於無施加電壓之狀態下點亮LED背光,調整液晶顯示元件之配置角度,使透過之光線亮度達最小之狀態。接著,對此液晶顯示元件施加頻率30Hz之交流電壓,並同時測定V-T曲線(電壓-透過率曲線),算出相對透過率為23%之交流電壓,以作為驅動電壓。 The prepared liquid crystal display element is placed between two polarizing plates with polarization axes arranged in a vertically crossed manner. The LED backlight is turned on without applying voltage, and the configuration angle of the liquid crystal display element is adjusted to minimize the brightness of the light passing through. Then, an alternating voltage with a frequency of 30Hz is applied to the liquid crystal display element, and the V-T curve (voltage-transmittance curve) is measured at the same time. The alternating voltage with a relative transmittance of 23% is calculated as the driving voltage.

驅動後閃爍度之測定方法為,於液晶顯示元件之溫度為23℃之狀態的溫度條件下,關閉已點亮之LED背光,於72小時間遮光放置後,再度點亮,並於背光點亮開始的 同時施加相對透過率為23%之頻率30Hz的交流電壓,對液晶顯示元件進行60分鐘之驅動,並追蹤閃爍之振幅。閃爍之振幅為使用與光二極體及I-V變換增幅器連接之資料擷取/資料記錄切換裝置34970A(Agilent technologies公司製),讀取通過兩片偏光板及於其中間的液晶顯示元件之亮度值。閃爍度(FL)為依以下式(VII)而算出,當閃爍度越低則該表示以該液晶配向劑所製得之液晶顯示元件品質越佳。 The method for measuring the flicker after driving is to turn off the LED backlight that has been turned on under the temperature condition that the temperature of the liquid crystal display element is 23℃, and then turn it on again after being placed in a dark place for 72 hours. At the same time as the backlight starts to light up, an AC voltage with a relative transmittance of 23% and a frequency of 30Hz is applied to the liquid crystal display element for 60 minutes, and the amplitude of the flicker is tracked. The amplitude of the flicker is read using a data acquisition/data recording switching device 34970A (made by Agilent technologies) connected to a photodiode and an I-V conversion amplifier, and the brightness value of the liquid crystal display element passing through the two polarizing plates and between them is read. The flicker (FL) is calculated according to the following formula (VII). The lower the flicker, the better the quality of the liquid crystal display element made with the liquid crystal alignment agent.

Figure 109123631-A0305-02-0061-226
Figure 109123631-A0305-02-0061-226

於式(VII)中,z為使用上述裝置34970A,以相對透過率為23%之頻率30Hz的交流電壓驅動時所讀取之亮度值。 In formula (VII), z is the brightness value read when the above device 34970A is driven by an AC voltage with a relative transmittance of 23% and a frequency of 30Hz.

※:FL<2%。 ※:FL<2%.

◎:3%>FL≧2%。 ◎: 3%>FL≧2%.

○:4%>FL≧3%。 ○: 4%>FL≧3%.

△:5%>FL≧4%。 △: 5%>FL≧4%.

×:FL≧5%。 ×: FL≧5%.

由第2與3表之結果可知,若本發明液晶配向劑之四羧酸二酐組份(a)不包含如式(I)所示之四羧酸二酐化合物(a-1)時,所形成之液晶顯示元件的驅動後即時之閃爍程度不佳。其次,若本發明液晶配向劑之二胺組分(b)不包含如式(II)所示之二胺化合物(b-1)時,所形成之液晶顯示 元件的驅動後即時之閃爍程度不佳。 From the results of Tables 2 and 3, it can be seen that if the tetracarboxylic dianhydride component (a) of the liquid crystal alignment agent of the present invention does not contain the tetracarboxylic dianhydride compound (a-1) as shown in formula (I), the degree of flickering of the liquid crystal display element formed after driving is not good. Secondly, if the diamine component (b) of the liquid crystal alignment agent of the present invention does not contain the diamine compound (b-1) as shown in formula (II), the degree of flickering of the liquid crystal display element formed after driving is not good.

若如式(II)所示之二胺化合物(b-1)具有如前述式(II-1-1)至式(II-1-3)所示之二胺化合物時,所形成之液晶顯示元件的驅動後即時之閃爍程度可更進一步地被降低。 If the diamine compound (b-1) shown in formula (II) has the diamine compounds shown in the aforementioned formulas (II-1-1) to (II-1-3), the flickering degree of the formed liquid crystal display element immediately after being driven can be further reduced.

另外,當本發明之液晶配向劑的二胺組份(b)包含如式(IV)所示之二胺化合物(b-2)時,所形成之液晶顯示元件的驅動後即時之閃爍程度可進一步被降低。 In addition, when the diamine component (b) of the liquid crystal alignment agent of the present invention contains a diamine compound (b-2) as shown in formula (IV), the flickering degree of the liquid crystal display element formed immediately after being driven can be further reduced.

需補充的是,本發明雖以特定的化合物、組成、反應條件、製程、分析方法或特定儀器作為例示,說明本發明之液晶配向劑、液晶配向膜及液晶顯示元件,惟本發明所屬技術領域中任何具有通常知識者可知,本發明並不限於此,在不脫離本發明之精神和範圍內,本發明之液晶配向劑、液晶配向膜及液晶顯示元件亦可使用其他的化合物、組成、反應條件、製程、分析方法或儀器進行。 It should be added that although the present invention uses specific compounds, compositions, reaction conditions, processes, analysis methods or specific instruments as examples to illustrate the liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element of the present invention, anyone with common knowledge in the technical field to which the present invention belongs can know that the present invention is not limited thereto. Without departing from the spirit and scope of the present invention, the liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element of the present invention can also use other compounds, compositions, reaction conditions, processes, analysis methods or instruments.

雖然本發明已以實施方式揭露如上,然其並非用以限定本發明,在本發明所屬技術領域中任何具有通常知識者,在不脫離本發明之精神和範圍內,當可作各種之更動與潤飾,因此本發明之保護範圍當視後附之申請專利範圍所界定者為準。 Although the present invention has been disclosed in the form of implementation as above, it is not intended to limit the present invention. Anyone with common knowledge in the technical field to which the present invention belongs can make various changes and modifications without departing from the spirit and scope of the present invention. Therefore, the scope of protection of the present invention shall be subject to the scope of the patent application attached hereto.

100:液晶顯示元件 100: Liquid crystal display element

110:第一單元 110: Unit 1

112:第一基板 112: First substrate

114:電極 114: Electrode

116:第一液晶配向膜 116: First liquid crystal alignment film

120:第二單元 120: Unit 2

122:第二基板 122: Second substrate

126:第二液晶配向膜 126: Second liquid crystal alignment film

130:液晶單元 130: Liquid crystal unit

Claims (10)

一種液晶配向劑,包含:一聚合物(A),由四羧酸二酐組份(a)及二胺組份(b)經一聚合反應而製得,其中該四羧酸二酐組份(a)包含至少一種如下式(I)所示之四羧酸二酐化合物(a-1),且該二胺組份(b)包含如下式(II)所示之二胺化合物(b-1):
Figure 109123631-A0305-02-0064-166
於該式(I)中,R1至R4各自獨立地代表氫原子、鹵素原子、碳數為1至6的烷基、碳數為2至6的烯基、碳數為2至6的炔基、含有氟原子且碳數為1至6的一價有機基團或苯基,R1至R4為相同或不相同,且R1、R2、R3及R4之至少一者不為氫原子;HN2-X1-M1-A-M2-X2-NH2 (II)於該式(II)中,M1與M2分別獨立地代表單鍵、-O-、-S-、-NM3-、酯基、醯胺基、硫酯基、脲基、碳酸酯基或胺基甲酸酯基,其中M3代表氫原子或甲基,且M1與M2可相同或不同;A代表碳數為2至20之伸烷基;X1與X2分別獨立地代表如下式(III-1)至式(III-19)所示之二價有機基團,且X1與X2係選自式(III-1)至式(III-19)中相異之二結構,其中X1與X2之至少一者代表如式(III-17)、式(III-18)或式(III-19)所示之結構:
Figure 109123631-A0305-02-0065-167
於該式(III-2)中,X3代表碳數為1至5之伸烷基;於該式(III-14)中,X4代表氫原子、鹵素原子、甲基、羥基或甲氧基;於該式(III-17)中,X5與X6分別獨立地代表鹵素原子、甲基、羥基或甲氧基;於該式(III-18)中,X7 與X8分別獨立地代表鹵素原子、甲基、羥基或甲氧基;以及一溶劑(B)。
A liquid crystal alignment agent comprises: a polymer (A) obtained by a polymerization reaction of a tetracarboxylic dianhydride component (a) and a diamine component (b), wherein the tetracarboxylic dianhydride component (a) comprises at least one tetracarboxylic dianhydride compound (a-1) represented by the following formula (I), and the diamine component (b) comprises a diamine compound (b-1) represented by the following formula (II):
Figure 109123631-A0305-02-0064-166
In the formula (I), R1 to R4 each independently represents a hydrogen atom, a halogen atom, an alkyl group having 1 to 6 carbon atoms, an alkenyl group having 2 to 6 carbon atoms, an alkynyl group having 2 to 6 carbon atoms, a monovalent organic group containing a fluorine atom and having 1 to 6 carbon atoms, or a phenyl group, R1 to R4 are the same or different, and at least one of R1 , R2 , R3 and R4 is not a hydrogen atom; HN2 - X1 - M1 - AM2 - X2 - NH2 (II) In the formula (II), M1 and M2 each independently represent a single bond, -O-, -S-, -NM3- , an ester group, an amide group, a thioester group, a urea group, a carbonate group or a carbamate group, wherein M3 represents a hydrogen atom or a methyl group, and M1 and M2 are not a hydrogen atom. 2 may be the same or different; A represents an alkylene group having 2 to 20 carbon atoms; X1 and X2 each independently represent a divalent organic group as shown in the following formula (III-1) to (III-19), and X1 and X2 are selected from two different structures in formula (III-1) to (III-19), wherein at least one of X1 and X2 represents a structure as shown in formula (III-17), formula (III-18) or formula (III-19):
Figure 109123631-A0305-02-0065-167
In the formula (III-2), X 3 represents an alkylene group having 1 to 5 carbon atoms; in the formula (III-14), X 4 represents a hydrogen atom, a halogen atom, a methyl group, a hydroxyl group or a methoxy group; in the formula (III-17), X 5 and X 6 each independently represent a halogen atom, a methyl group, a hydroxyl group or a methoxy group; in the formula (III-18), X 7 and X 8 each independently represent a halogen atom, a methyl group, a hydroxyl group or a methoxy group; and a solvent (B).
如請求項1所述之液晶配向劑,其中該二胺化合物(b-1)選自如下式(II-1-1)至式(II-1-3)所示之二胺化合物:
Figure 109123631-A0305-02-0066-168
Figure 109123631-A0305-02-0066-169
Figure 109123631-A0305-02-0066-170
於該式(II-1-1)至該式(II-1-3)中,A、M1、M2、X5、X6、X7與X8之定義如前所述。
The liquid crystal alignment agent as described in claim 1, wherein the diamine compound (b-1) is selected from the diamine compounds represented by the following formulas (II-1-1) to (II-1-3):
Figure 109123631-A0305-02-0066-168
Figure 109123631-A0305-02-0066-169
Figure 109123631-A0305-02-0066-170
In the formula (II-1-1) to the formula (II-1-3), A, M 1 , M 2 , X 5 , X 6 , X 7 and X 8 are as defined above.
如請求項1所述之液晶配向劑,其中該二胺組份(b)包含如下式(IV)所示之二胺化合物(b-2):
Figure 109123631-A0305-02-0066-171
於該式(IV)中,Z1與Z5分別獨立地代表單鍵、-CH2-或-CH2CH2-;Z2與Z4分別獨立地代表-CH2-或-CH2CH2-;Z3代表碳數為1至6之伸烷基或伸環己基;Y1與Y2分別獨立地代表單鍵、-O-、-NH-、-N(CH3)-、-C(=O)-、-C(=O)O-、-C(=O)NH-、-C(=O)N(CH3)-、-OC(=O)-、-NHC(=O)-或N(CH3)C(=O)-;Y3代表碳數為1至20之直鏈烴基、碳數為3至20之支鏈烴基或碳數為3至20之環狀烴基;且a代表0或1。
The liquid crystal alignment agent as described in claim 1, wherein the diamine component (b) comprises a diamine compound (b-2) represented by the following formula (IV):
Figure 109123631-A0305-02-0066-171
In the formula (IV), Z1 and Z5 each independently represent a single bond, -CH2- or -CH2CH2- ; Z2 and Z4 each independently represent -CH2- or -CH2CH2- ; Z3 represents an alkylene group or a cyclohexylene group having 1 to 6 carbon atoms; Y1 and Y2 each independently represent a single bond, -O-, -NH-, -N( CH3 )-, -C(=O)-, -C(=O)O-, -C(=O)NH-, -C (=O)N( CH3 )-, -OC(=O)-, -NHC(=O)- or N( CH3 )C(=O)-; Y 3 represents a linear alkyl group having 1 to 20 carbon atoms, a branched alkyl group having 3 to 20 carbon atoms, or a cyclic alkyl group having 3 to 20 carbon atoms; and a represents 0 or 1.
如請求項3所述之液晶配向劑,其中Y1與Y2分別獨立地代表單鍵或-O-。 A liquid crystal alignment agent as described in claim 3, wherein Y1 and Y2 independently represent a single bond or -O-. 如請求項3所述之液晶配向劑,其中a代表0。 A liquid crystal alignment agent as described in claim 3, wherein a represents 0. 如請求項1所述之液晶配向劑,其中基於該四羧酸二酐組份(a)的總使用量為100莫耳,該四羧酸二酐化合物(a-1)的使用量為10莫耳至100莫耳,且基於該二胺組份(b)之總使用量為100莫耳,該二胺化合物(b-1)之使用量為5莫耳至50莫耳。 The liquid crystal alignment agent as described in claim 1, wherein the amount of the tetracarboxylic dianhydride compound (a-1) used is 10 mol to 100 mol based on the total amount of the tetracarboxylic dianhydride component (a) used is 100 mol, and the amount of the diamine compound (b-1) used is 5 mol to 50 mol based on the total amount of the diamine component (b) used is 100 mol. 如請求項3所述之液晶配向劑,其中基於該二胺組份(b)之總使用量為100莫耳,該二胺化合物(b-2)之使用量為1莫耳至10莫耳。 The liquid crystal alignment agent as described in claim 3, wherein the total usage amount of the diamine component (b) is 100 mol, and the usage amount of the diamine compound (b-2) is 1 mol to 10 mol. 如請求項1所述之液晶配向劑,其中基於該聚合物(A)之總使用量為100重量份,該溶劑(B)之使用量為800重量份至4000重量份。 The liquid crystal alignment agent as described in claim 1, wherein the total amount of the polymer (A) used is 100 parts by weight, and the amount of the solvent (B) used is 800 parts by weight to 4000 parts by weight. 一種液晶配向膜,利用如請求項1至8中之任一項所述之液晶配向劑所形成。 A liquid crystal alignment film formed using a liquid crystal alignment agent as described in any one of claims 1 to 8. 一種液晶顯示元件,包含如請求項9所述之液晶配向膜。 A liquid crystal display element, comprising a liquid crystal alignment film as described in claim 9.
TW109123631A 2020-07-13 2020-07-13 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element TWI849179B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TW109123631A TWI849179B (en) 2020-07-13 2020-07-13 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
CN202110766729.XA CN113930248B (en) 2020-07-13 2021-07-07 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW109123631A TWI849179B (en) 2020-07-13 2020-07-13 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element

Publications (2)

Publication Number Publication Date
TW202202603A TW202202603A (en) 2022-01-16
TWI849179B true TWI849179B (en) 2024-07-21

Family

ID=79274322

Family Applications (1)

Application Number Title Priority Date Filing Date
TW109123631A TWI849179B (en) 2020-07-13 2020-07-13 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element

Country Status (2)

Country Link
CN (1) CN113930248B (en)
TW (1) TWI849179B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201908369A (en) * 2017-06-08 2019-03-01 日商日產化學工業股份有限公司 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TW202024755A (en) * 2018-08-20 2020-07-01 日商日產化學股份有限公司 Liquid crystal alignment agent, manufacturing method thereof, liquid crystal alignment film and liquid crystal display element

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4665487B2 (en) * 2003-11-05 2011-04-06 チッソ株式会社 New diamine and polymer made from it
JP4779339B2 (en) * 2003-11-05 2011-09-28 Jnc株式会社 Liquid crystal aligning agent and liquid crystal display element using the same
JP5569095B2 (en) * 2010-03-29 2014-08-13 Jnc株式会社 Diamine having diphenylamine structure at two positions in the molecule, polymer obtained by reacting this diamine, liquid crystal aligning agent containing this polymer, liquid crystal aligning film formed using this liquid crystal aligning agent, and this liquid crystal aligning film Liquid crystal display device having
JP6056187B2 (en) * 2012-05-09 2017-01-11 Jnc株式会社 Liquid crystal alignment agent, liquid crystal alignment film for forming liquid crystal alignment film for photo-alignment, and liquid crystal display element using the same
US11130320B2 (en) * 2014-07-11 2021-09-28 Samsung Electronics Co., Ltd. Transparent polymer film and electronic device including the same
JP7351295B2 (en) * 2018-04-09 2023-09-27 日産化学株式会社 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element using the same
CN112912792B (en) * 2018-10-18 2025-10-17 日产化学株式会社 Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element using same
KR20250165703A (en) * 2018-11-14 2025-11-26 닛산 가가쿠 가부시키가이샤 Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element using same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201908369A (en) * 2017-06-08 2019-03-01 日商日產化學工業股份有限公司 Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TW202024755A (en) * 2018-08-20 2020-07-01 日商日產化學股份有限公司 Liquid crystal alignment agent, manufacturing method thereof, liquid crystal alignment film and liquid crystal display element

Also Published As

Publication number Publication date
CN113930248A (en) 2022-01-14
TW202202603A (en) 2022-01-16
CN113930248B (en) 2025-02-11

Similar Documents

Publication Publication Date Title
KR101396735B1 (en) Liquid crystal aligning agent and liquid crystal display device
CN104342171B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element containing liquid crystal alignment film
TWI521017B (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
JP2007241249A (en) Vertical alignment type liquid crystal aligning agent and vertical alignment type liquid crystal display element
CN110499164A (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
CN104178181B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
CN106398722B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
CN104449765B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
KR101010461B1 (en) Liquid crystal aligning agent and liquid crystal display element
JP4900571B2 (en) Vertical liquid crystal aligning agent and vertical liquid crystal display element
KR20080023646A (en) Liquid crystal aligning agent and liquid crystal display element
JP2019003188A (en) Method for producing liquid crystal alignment film and liquid crystal display element
JP5105092B2 (en) Liquid crystal alignment film, method for forming the same, and liquid crystal display element
JP2008225010A (en) Liquid crystal aligning agent and liquid crystal display element
JP4985906B2 (en) Vertical liquid crystal aligning agent and vertical liquid crystal display element
JP4788899B2 (en) Liquid crystal aligning agent and liquid crystal display element
TWI874658B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TWI849179B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
CN112852446B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TWI884287B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
TWI660981B (en) Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element having the same
TWI834894B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element
CN113773858B (en) Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display assembly
JP5339062B2 (en) Liquid crystal aligning agent and liquid crystal display element
JP4844712B2 (en) Liquid crystal aligning agent and liquid crystal display element